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Abstract
Peroxisomes are key metabolic organelles, which contribute to cellular lipid metabolism, e.g. the β-oxidation of fatty acids 
and the synthesis of myelin sheath lipids, as well as cellular redox balance. Peroxisomal dysfunction has been linked to severe 
metabolic disorders in man, but peroxisomes are now also recognized as protective organelles with a wider significance 
in human health and potential impact on a large number of globally important human diseases such as neurodegeneration, 
obesity, cancer, and age-related disorders. Therefore, the interest in peroxisomes and their physiological functions has sig-
nificantly increased in recent years. In this review, we intend to highlight recent discoveries, advancements and trends in 
peroxisome research, and present an update as well as a continuation of two former review articles addressing the unsolved 
mysteries of this astonishing organelle. We summarize novel findings on the biological functions of peroxisomes, their 
biogenesis, formation, membrane dynamics and division, as well as on peroxisome–organelle contacts and cooperation. 
Furthermore, novel peroxisomal proteins and machineries at the peroxisomal membrane are discussed. Finally, we address 
recent findings on the role of peroxisomes in the brain, in neurological disorders, and in the development of cancer.
Keywords ACBD5 · Alzheimer · Cancer · Hearing loss · Membrane contact sites · Motility · Multiple sclerosis · Organelle 
biogenesis · Organelle division · Organelle dynamics · Parkinson · Peroxin · Peroxisome
Abbreviations
ACBD  Acyl-CoA-binding domain
ACOX  Acyl-CoA oxidase
CNS  Central nervous system
EE  Early endosome
ER  Endoplasmic reticulum
MFP  Multifunctional protein
MS  Multiple sclerosis
NO  Nitric oxide
PBD  Peroxisome biogenesis disorder
Pex  Peroxin
PMP  Peroxisomal membrane protein
PPAR  Peroxisome peroxisome-proliferator receptor
PTS  Peroxisomal targeting signal
ROS  Reactive oxygen species
SED  Single enzyme deficiency
VLCFA  Very long chain fatty acids
X-ALD  X-linked adrenoleukodystrophy
Introduction
The interest in peroxisomes and their (patho)physiological 
roles in health and disease is constantly increasing within the 
scientific community, and there is no doubt that peroxisomes 
are on the rise. Since their discovery more than 60 years ago 
(Rhodin 1954), essential metabolic functions of peroxisomes 
[e.g. in lipid metabolism including fatty acid β-oxidation and 
synthesis of myelin sheath lipids, or metabolism of reac-
tive oxygen species (ROS), in particular, hydrogen perox-
ide] have been revealed, demonstrating that peroxisomes 
are key metabolic organelles, and their dysfunction has 
been linked to severe metabolic disorders in man. In recent 
years, it became clear that peroxisomes also fulfil crucial 
non-metabolic roles, e.g. in cellular stress responses, the 
combat of pathogens and antiviral defence, as cellular sig-
nalling platforms and in healthy ageing. These findings indi-
cate that peroxisomes are also “protective” organelles with a 
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wider significance in human health and potential impact on 
a large number of globally important human diseases such 
as neurodegeneration, obesity, cancer, and age-related disor-
ders. However, many physiological roles of peroxisome still 
remain enigmatic. Here, we will highlight recent discoveries, 
advancements and trends in peroxisome research, which, we 
hope, will also aid non-experts and those who are not up to 
date with the current developments to get an overview of 
the field of peroxisome biology. This review represents an 
update as well as a continuation of two articles of our “mys-
tery” series we published in Histochemistry and Cell Biol-
ogy [the 1st on the occasion of the 50th anniversary of the 
journal in 2008 (Schrader and Fahimi 2008; Islinger et al. 
2012a, b)]. To avoid repetition, we will refer to those articles 
when appropriate and to more specialized recent reviews 
on peroxisome biology. New advances in the understanding 
of pexophagy, the controlled removal of peroxisomes, are 
addressed by Kovacs and coworkers (see this issue) (Eber-
hart and Kovacs 2018).
Mysterious functions: an update 
on peroxisomal metabolism
An organelle—underrated at the beginning—
hesitantly discloses its mysteries
The subcellular structure delineated by a single membrane 
surrounding a granular homogeneous matrix, discovered in 
rodent kidney cells and subsequently in liver, and termed 
“microbody” to meet its morphology (Rhodin 1954; Rouiller 
and Bernhard 1956), initially had the standing of a cell odd-
ity with no clear role in vital functions and intermediary 
metabolism. In the succeeding decades, however, evidence 
accumulated progressively converting the obscure “Cinder-
ella” amongst the known cell organelles to a multifunctional 
global player with profound and far-reaching relevance for 
health and disease of animal and plant organisms.
Initiated by the pioneering work of De Duve`s group with 
the clear-cut biochemical individualisation and characteriza-
tion of microbodies—since then renamed peroxisomes—(De 
Duve 1965; De Duve and Baudhuin 1966; see Vamecq et al. 
2014 for further ref.), and the observation that peroxisomes 
are lacking in Zellweger patients (Goldfischer et al. 1973), it 
is now well documented that peroxisomes are indispensable 
to eukaryotic cells and hence virtually ubiquitously distrib-
uted. They are unique in their morphological heterogeneity 
(see “Peroxisome heterogeneity”) and display a remarkable 
functional plasticity in both anabolic and catabolic pro-
cesses, specifically adapted in their proteome to cell type, 
growth conditions and variable environment (see “Mysteri-
ous machinery: new proteins and functions at the peroxi-
somal membrane”). Last but not least, they are involved in 
fundamental vital processes such as the detoxification of 
dangerous oxygen/nitrogen species (Fransen et al. 2012), 
are signalling platforms (Mast et al. 2015), with critical roles 
for innate immunity (Dixit et al. 2010) as well as develop-
ment and differentiation (Titorenko and Rachubinski 2004), 
and intimately communicate with other organelles (Schrader 
et al. 2013; Shai et al. 2016). Dysfunctions or even lack of 
peroxisomes not only underlie the well-known peroxisomal 
disorders, but also contribute to physio- as well as patho-
physiological processes such as ageing and related diseases 
(Deori et al. 2018) or cancer (see “Peroxisomes and cancer: 
a mysterious connection”).
To contribute in concert to the well-being of a cell, and 
to optimize their multiple functions, peroxisomes collabo-
rate and communicate with other cell organelles. Numerous 
mechanisms have evolved enabling such a crosstalk includ-
ing signal transduction pathways, vesicular trafficking and 
contact sites (see “Peroxisome–organelle interactions: the 
mysterious world of tethers”; Shai et al. 2016). Crosstalk 
between peroxisomes, the ER and the mitochondria is the 
most common, yet neither the underlying mechanisms nor 
the functional relevance is experimentally verified in great 
detail (Shai et al. 2016 and ref. therein).
The impact peroxisomes evidently have on lipid metabo-
lism is best documented by the accumulation of very long 
chain fatty acids (VLCFA) in plasma, and the complete 
deficiency of plasmalogens in tissues of Zellweger patients 
(Brown et al. 1982; Heymans et al. 1983). Ether lipid synthe-
sis occurs in peroxisomes and begins with the esterification 
of dihydroxyacetone phosphate (DHAP) with a long-chain 
fatty acid by the enzyme DHAP acyltransferase (DHAPAT), 
and the subsequent replacement of the fatty acid by a fatty 
alcohol to form alkyl-DHAP by alkyl-glycerone phosphate 
synthase (AGPS). Remarkably, the critical AGPS enzyme 
is heightened in aggressive cancer cells and primary human 
breast tumors, and its genetic ablation significantly impairs 
cancer aggressiveness and tumorigenesis (Benjamin et al. 
2013). Since it could be demonstrated that AGPS knock-
down had dramatic effects upon tumor growth in mice, and 
inhibition of AGPS activity lowers ether lipids and impairs 
cancer pathogenicity in different types of human cancer cells 
(Piano et al. 2015), the development of efficacious appropri-
ate inhibitors might be crucial in cancer therapy.
Peroxisomes and mitochondria interact intensively, inter 
alia, in fatty acid (Wanders 2014), as well as ROS metabo-
lism (Fransen et al. 2012; Lismont et al. 2015), and in the 
detoxification of glyoxylate and phytanic acid (Wanders 
et al. 2011). Most importantly, peroxisomes exclusively 
β-oxidize VLCFA. Increased concentrations of VLCFA are 
found in body fluids and tissues of patients with X-ALD as 
well as acyl-CoA oxidase 1 (ACOX1) deficiency, affecting 
in particular the nervous system (Wanders et al. 2010 and 
ref. therein). Appropriate cytotoxic properties of VLCFA 
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reported include inflammatory demyelination and axonopa-
thy, cell death of oligodendrocytes and astrocytes, dereg-
ulation of intracellular  Ca2+ homeostasis, and a marked 
decrease of the membrane potential of mitochondria in oli-
godendrocytes (Hein et al. 2008; see also “News from the 
brain: unravelling the mysterious role of peroxisomes in the 
central nervous system (CNS)”).
In mammalian organisms including humans, α-oxidation 
of 3-methyl-branched-chain fatty acids such as phytanic acid 
is a strictly peroxisomal process. To explain the toxic prop-
erties of phytanic acid when not properly processed, it was 
initially hypothesized that its incorporation into membranes 
disrupts the arrangement of lipids and their interactions with 
proteins, hence their integrity. Alternatively, based on the 
notion that the chemical structure of phytanic acid shows 
similarities to that of the vitamins A, E, and K, phytanic 
acid could act as an anti-metabolite with respect to these 
isoprenoids. Subsequent in vitro studies mainly focused 
on the effects of phytanic acid on mitochondria (Schönfeld 
and Struy 1999), yet it remains to be clarified whether these 
in vitro effects also meet the in vivo situation of Refsum 
disease.
Peroxisome heterogeneity
The heterogeneity of peroxisomes was already noted in early 
electron microscopic studies, when they were still referred to 
as “microbodies and related particles” (Hruban and Rechcigl 
1969). The discovery of hydrogen peroxide metabolism and 
the designation as “peroxisome” emphasized the similar-
ity and the close relationship of this group of organelles 
in animal and plant cells (De Duve and Baudhuin 1966). 
But subsequent studies revealed the characteristic features 
of peroxisomes of different organs, e.g. the marked differ-
ences between peroxisomes from rat liver and brain (Gaunt 
and de Duve 1976). Moreover, the alterations of enzymes 
of peroxisomes in the course of pre- and post-natal devel-
opment revealed the capability of this organelle to adapt to 
differing metabolic requirements of the organism (Krahl-
ing et al. 1979). For a review on the diversity of peroxi-
somes in the animal kingdom, see Islinger et al. (2010). The 
heterogeneity of peroxisomes can be clearly demonstrated 
by the cytochemical technique for D-amino acid oxidase 
using cerium (Angermüller and Fahimi 1988; Angermüller 
1989). In rat hepatocytes, a mosaic pattern with strongly 
and weakly reactive peroxisomes is observed with overall 
staining being stronger in peri-portal (high oxygen conc.) 
than in peri-central (low oxygen conc.) parts of the liver 
lobule. In the kidney, the proximal tubules of the renal cor-
tex are strongly stained with the rest of the nephron being 
negative. In particular, in some cells, strongly and weakly 
stained peroxisomes are present side by side within the same 
cells (Angermüller and Fahimi 1988). The existence of het-
erogeneous subpopulations of peroxisomes has also been 
observed in biochemical studies when peroxisomes were 
isolated (Lüers et al. 1993; Islinger et al. 2012) and in mor-
phological studies with cultured mammalian cells (Schrader 
et al. 1994) or during fungal development (Takano-Rojas 
et al. 2016). These differences have been linked to peroxi-
some formation and maturation (see “Peroxisome formation: 
mysterious with a new twist” and “Mysterious multiplica-
tion: new insights into peroxisome division”). Interestingly, 
both, de novo formation of peroxisomes from the ER via 
pre-peroxisomal vesicles or from pre-existing organelles 
via membrane growth and division, lead to the formation 
of membrane compartments which mature by subsequent 
import of matrix proteins (Hoepfner et al. 2005; Delille et al. 
2010). The matrix protein content of pre-existing peroxi-
somes is therefore not evenly distributed over new organelles 
indicating that peroxisome formation by division is an asym-
metric process (Huybrechts et al. 2009; Delille et al. 2010). 
Peroxisomes display an age-related heterogeneity with 
respect to their capacity to incorporate newly synthesized 
proteins (Huybrechts et al. 2009) and segregation during cell 
division (Kumar et al. 2018). This also applies to peroxiso-
mal membrane proteins (PMPs), which reorganize in the per-
oxisomal membrane during membrane growth and division 
(Delille et al. 2010; Cepińska et al. 2011). The application 
of super-resolution microscopy supported the notion that 
PMPs are compartmentalized (Galiani et al. 2016; Soliman 
et al. 2018). A further degree of heterogeneity (and PMP 
compartmentalisation) is achieved by the dynamic formation 
of membrane contact sites with other organelles, e.g. the 
ER (see “Peroxisome–organelle interactions: the mysterious 
world of tethers”). Tethering impacts on peroxisome motility 
and likely explains why only a subset of peroxisomes exhib-
its long-range movement along cytoskeletal tracks resulting 
in a heterogeneous motile behaviour (Costello et al. 2017; 
Castro et al. 2018a, b) (see “Peroxisome motility and distri-
bution: mysterious movers”).
Mysterious machinery: new proteins 
and functions at the peroxisomal membrane
News on peroxins, protein import, molecular 
mechanisms and membrane adaptors
Peroxisome biogenesis involves the generation of the per-
oxisomal membrane and subsequent targeting and inser-
tion of PMPs into the lipid bilayer, as well as the import 
of enzymes/proteins into the peroxisomal matrix. In con-
trast to other organelles such as mitochondria or the ER, 
peroxisomes can import completely folded and oligomeric 
or cofactor-bound proteins through a dynamic protein 
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translocon (Meinecke et al. 2010; Montilla-Martinez et al. 
2015; Dias et al. 2017). The import of matrix proteins and 
(most) PMPs involves largely conserved, but distinct import 
machineries with unique properties (Figs. 1, 2). Essential 
biogenesis factors, so-called peroxins (Pex proteins) form 
the import machineries. Since our last review in 2012, the 
number of identified peroxins has increased to 36. Pex9 is 
a new Pex5-like yeast peroxisomal targeting receptor for a 
subset of PTS1 (peroxisomal targeting signal)-containing 
matrix proteins during growth in oleate (Effelsberg et al. 
2016; Yifrach et al. 2016). The existence of two distinct 
PTS1 receptors, Pex5 and Pex9 (in addition to PTS2-depend-
ent import routes), allows yeast cells to adapt the metabolic 
capacity of peroxisomes to environmental changes. Pex35 
was also identified as a new peroxisomal membrane protein 
in yeast, which is a regulator of peroxisome abundance (Yofe 
et al. 2017) whilst the new yeast peroxin, Pex36, a func-
tional homolog of mammalian Pex16, functions in the ER-
to-peroxisome traffic of PMPs (Farré et al. 2017). Finally, a 
role in the import of matrix proteins required for fatty acid 
β-oxidation and bile acid synthesis was proposed for the 
peroxisomal transmembrane protein TMEM135 (PMP52), 
which has high homology to the TIM17 family that mediates 
protein translocation across mitochondrial membranes (Ren-
quist et al. 2018). TMEM135 was identified as a novel target 
of liver x receptors (LXRs), which belong to the nuclear 
receptor superfamily and are key regulators of cholesterol 
and fatty acid metabolism (Renquist et al. 2018).
With respect to matrix protein import, the processes of 
cargo translocation and receptor recycling are still debated 
(reviewed in Francisco et al. 2017). Progress has been made 
in the understanding of the unique structure and molecu-
lar function of the peroxisomal AAA–ATPase Pex1/Pex6 
complex, which is involved in the export and recycling of 
the ubiquitinated import receptors Pex5 and Pex7 (Ciniaw-
sky et al. 2015; Blok et al. 2015; reviewed in Schwerter 
et al. 2017) (Figs. 1, 2). Very recently, it was shown that 
the AAA–ATPase Pex1/Pex6 unfolds substrates by proces-
sive threading (Gardner et al. 2018), and that monoubiquit-
inated Pex5, which interacts with the AAA–ATPases Pex1 
and Pex6, is unfolded during its dislocation to the cytosol 
(Pedrosa et al. 2018).
Interestingly, further evidence has now been provided 
that human Pex5 can function as a redox/stress sensor to 
retain peroxisomal catalase in the cytosol to combat oxida-
tive stress of non-peroxisomal origin (Walton et al. 2017). 
Remarkably, small molecule inhibitors of peroxisomal (gly-
cosomal) protein import (directed against Pex14) have been 
developed, which efficiently disrupt glycosomal matrix pro-
tein import in Trypanosoma parasites. This results in mislo-
calization of glycosomal enzymes, causing metabolic catas-
trophe and death of the parasite (Dawidowski et al. 2017). 
These are examples which link peroxisomal protein import 
to redox homeostasis and healthy ageing, and to the combat 
of parasites and the development of new therapies against 
trypanosomiases.
The import/insertion of PMPs depends on the membrane 
biogenesis factors Pex19, Pex16 and Pex3 (Fig. 1, 2). Excel-
lent reviews on peroxisomal membrane biogenesis and PMP 
targeting and integration into the lipid bilayer have recently 
been published in a special issue on the assembly, mainte-
nance and dynamics of peroxisomes published in Biochim 
Biophys Acta—Molecular Cell Research [Erdmann (Ed.) 
2016]. This issue also contains comprehensive reviews 
about matrix protein import. New insight has meanwhile 
been obtained in the targeting, insertion and quality control 
of tail-anchored membrane proteins at peroxisomes. Recent 
studies support a direct, Pex19-dependent pathway (Yagita 
et al. 2013; Costello et al. 2017a, b, c) and a hydrophobic 
handoff mechanism for membrane insertion (Chen et al. 
2014). Furthermore, targeting information in peroxisomal 
TA proteins has been revealed, and new peroxisomal TA 
proteins have been predicted and identified (Buentzel et al. 
2015; Costello et al. 2017a, b, c). Those include the per-
oxisome–ER tether ACBD4 and the motor protein adaptor 
MIRO1 (see “Peroxisome–organelle interactions: the myste-
rious world of tethers” and “Peroxisome motility and distri-
bution: mysterious movers”) (Fig. 1). Furthermore, a role for 
the AAA protein Msp1/ATAD1 in the clearance of excess 
tail-anchored proteins from the peroxisomal membrane has 
been revealed (Weir et al. 2017) (Fig. 1, 2). Many of those 
TA proteins, which act as membrane adaptors for important, 
disease-relevant cellular processes, are shared with mito-
chondria (see “Mysterious multiplication: new insights into 
peroxisome division” and “Peroxisome–organelle inter-
actions: the mysterious world of tethers”) (Schrader et al. 
2015a, b) (Fig. 1, 2).
Peroxisome formation: mysterious with a new twist
It is now accepted that peroxisomes can form via the classi-
cal route of growth and division of pre-existing organelles, 
or via an alternate route of de novo formation of nascent 
peroxisomes (for recent reviews see Hettema et al. 2014; 
Agrawal and Subramani 2016). The latter pathway is based 
on studies in mutant cells lacking peroxisomes due to a loss 
of the membrane biogenesis factors Pex3, Pex16 or Pex19. 
However, peroxisome numbers appear to be primarily con-
trolled by growth and division (Motley and Hettema 2007). 
The de novo model suggests that several key PMPs (e.g. 
Pex3) target the ER, sequester into pre-peroxisomal vesi-
cles, which are released and form import-competent peroxi-
somes which then grow and divide to multiply (Hoepfner 
et al. 2005). There was some debate about the initiation of 
de novo formation at the ER, as pre-peroxisomal vesicles 
were also observed in yeast cells lacking Pex3 or Pex19. 
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Fig. 1  Schematic overview of the molecular machineries and proteins 
localized at the membranes of peroxisomes in mammals. Adapted 
from Schrader and Fahimi (2008). See text for further details. Matrix 
protein import: after synthesis on free ribosomes, cargo proteins con-
taining the peroxisomal targeting signals PTS1 or PTS2 bind to the 
corresponding cytosolic receptors Pex5 or Pex7 and form receptor–
cargo complexes. The Pex7–cargo complex requires accessory factors 
for import (Pex5pL, a long isoform of Pex5p, in mammals and plants, 
Pex18p and Pex21p in S. cerevisiae, Pex20p in Neurospora crassa, 
Yarrowia lipolytica, and Hansenula polymorpha). Pex9 is a new 
Pex5-like yeast peroxisomal targeting receptor. Import is achieved 
by a complex set of integral or peripheral PMPs that form the matrix 
protein import machinery, which mediates docking of the cargo-
bound import receptor at the peroxisomal membrane, cargo translo-
cation into the matrix of the organelle by a dynamic translocon, and 
export of the receptor back to the cytosol. Recycling of the receptor 
involves its ubiquitination (ub) and extraction from the membrane by 
an AAA–ATPase complex (Pex1, Pex6). Pex4 is an ubiquitin-conju-
gating enzyme that is bound to Pex22. Pex6 binds to Pex15 in S. cer-
evisiae or to Pex26 in humans. The DnaJ-like protein Djp1p assists 
in matrix protein import. Membrane assembly and insertion of PMPs 
(containing an mPTS) depend on Pex19, Pex3 and Pex16. Pex19 
functions as a cycling receptor/chaperone, which binds the PMPs in 
the cytosol and interacts with Pex3 at the peroxisomal membrane. 
Yeast Pex36 is a new functional homolog of mammalian Pex16. 
Proliferation, growth and division: Pex11α, Pex11β and Pex11γ are 
involved in the regulation of peroxisome size and number (prolifera-
tion) in mammals. In Y. lipolytica (Pex23, Pex24) and S. cerevisiae 
(Pex25, Pex27-Pex32, Pex34, Pex35) several other peroxins have 
been identified which influence the size and number or organization 
of peroxisomes. Mammalian Pex11β remodels the peroxisomal mem-
brane and interacts with the membrane adaptors Mff and Fis1, which 
recruit the dynamin-like fission GTPase Drp1 (DRP3A in plants, 
Vps1p, Dnm1p in S. cerevisiae) to peroxisomes, which is activated 
by Pex11β. Additional adaptor proteins are involved in yeast (Mdv1, 
Caf4) and plants (PMD1; see text). Motility and inheritance: mam-
malian peroxisomes move along microtubules, and Miro1 serves 
as membrane adaptor for the microtubule-dependent motor pro-
teins kinesin and dynein. Inp1 and Inp2 are involved in the inherit-
ance and motility of peroxisomes in S. cerevisiae and Y. lipolytica. 
Inp2 is the membrane receptor for the type V myosin motor Myo2 
on peroxisomes, which drives peroxisomes along actin filaments. 
The GTPase Rho1 binds to Pex25 and is involved in the recruitment 
of actin to peroxisomes in S. cerevisiae. Tethering: ACBD5 and 
ACBD4 interact with ER-resident VAPA/B to mediate peroxisome–
ER contacts in mammals. In yeast, Inp1, Pex3, Pex30 and Pex34 are 
involved in inter-organelle contacts (ER and mitochondria) (see also 
Fig.  3). Metabolite transport: uptake of fatty acids is mediated by 
ABC transporter proteins (ABCD1-3 in mammals; Pxa1-2 in yeast) 
(ALD, adrenoleukodystrophy protein; ALDR, ALD-related protein). 
Other transporter and membrane proteins/enzymes: OCTN3, organic 
cation/carnitine transporter 3; MCT1/2, monocarboxylate transporter 
1/2; Opt2, yeast oligopeptide transporter (Elbaz-Alon et  al. 2014); 
PMP52 (Tmem135) and PMP24 (PxmP4) belong to the Tim17 fam-
ily (Žárský and Doležal 2016); members of the PMP22 family are 
Mpv17, Mpv17-like (ML-P), S. cerevisiae Sym1 (mitochondrial) and 
WSC (Woronin body sorting complex) in N. crassa; ACSL1/4, acyl-
CoA synthetase long chain family member 1/4; Ant1, peroxisomal 
adenine nucleotide transporter 1; mARC2 (Mosc2), mitochondrial 
amidoxime reducing component 2; ATAD1/Msp1, ATPase family 
AAA (ATPase associated with various cellular activities) domain-
containing protein 1; Atg37, autophagy-related protein 37 (Nazarko 
et  al. 2014); FALDH, fatty aldehyde dehydrogenase (Costello et  al. 
2017a, b, c); FAR1, fatty acyl-CoA reductase 1 (ether lipid biosyn-
thesis); GDAP1, ganglioside-induced differentiation-associated pro-
tein 1; MAVS, mitochondrial antiviral signalling protein; TRIM37, 
tripartite motif-containing protein 37; USP30, ubiquitin-specific pro-
tease 30 (Marcassa et  al. 2018). Proteins with a dual localization to 
both peroxisomes and mitochondria are marked with an asterisk. Pex, 
peroxin; PMP, peroxisomal membrane protein
 Histochemistry and Cell Biology
1 3
These vesicles were degraded by autophagy and had, there-
fore, been overlooked (Knoops et al. 2014; Wróblewska 
et al. 2017). Recent studies in yeast have, however, revealed 
a role for the reticulon-like proteins Pex30 and Pex31 in the 
generation of an ER subdomain in which pre-peroxisomal 
vesicles bud (David et al. 2013; Mast et al. 2016; Joshi et al. 
2016). Furthermore, a role for ESCRT-III proteins Vps20 
and Snf7 in the release of pre-peroxisomal vesicles from 
the ER was identified (Mast et al. 2018), supporting the ER 
origin of pre-peroxisomal vesicles. In addition, Pex36, a new 
yeast peroxin and functional homolog of mammalian Pex16, 
has been identified, which functions in ER-to-peroxisome 
trafficking of peroxisomal membrane proteins (Farré et al. 
2017) (Fig. 1, 2).
Studies with human patient fibroblasts lacking Pex3 or 
Pex16, which are devoid of peroxisomes, added another 
twist to the model of de novo biogenesis (Sugiura et al. 
2017). When Pex3 was re-introduced, it targeted mitochon-
dria and was released in pre-peroxisomal vesicles. Pex16, 
on the other hand, targeted the ER, where it exited in pre-
peroxisomal vesicles that appeared to fuse with the mito-
chondria-derived pre-peroxisomes to generate new, import-
competent peroxisomes (Sugiura et al. 2017). Thus, both ER 
and mitochondria can contribute to the de novo formation 
of peroxisomes in mammalian cells. The initial targeting 
of PMPs in the absence of peroxisomes may, therefore, be 
a key event in de novo formation (for recent reviews/com-
mentaries, see Hettema and Gould 2017; Schrader and Pel-
legrini 2017; Costello and Schrader 2018). The ER-derived 
biogenic route and the physiological role of the de novo 
pathway are still controversially discussed, but it is recog-
nized that the ER makes important contributions to peroxi-
some biogenesis and that peroxisomes are semi-autonomous 
organelles, which depend on other cellular compartments 
such as the ER to obtain lipids or even specific proteins (see 
“Peroxisome–organelle interactions: the mysterious world of 
tethers”) (Titorenko and Rachubinski 2014) (Fig. 3).
Mysterious multiplication: new insights 
into peroxisome division
Peroxisomes are dynamic organelles which can multiply by 
membrane growth and division of pre-existing organelles 
(reviewed in Islinger et al. 2012a, b; Schrader et al. 2016). 
This involves remodelling and expansion of the peroxiso-
mal membrane through the formation of tubular membrane 
extensions which then constrict and divide into new peroxi-
somes. In mammals, this is supposed to be an asymmetric 
process, which forms new peroxisomes via generation of a 
membrane compartment and subsequent import of newly 
Fig. 2  Schematic overview of the 
molecular machineries and pro-
teins localized at the membranes 
of yeast peroxisomes. Adapted 
from (Schrader and Fahimi 
2008). See legend Fig. 1 and text 
for further details
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synthesized matrix proteins (Huybrechts et al. 2009; Delille 
et al. 2010). The membrane peroxin Pex11β is a key factor in 
the regulation of peroxisome number in mammals, which has 
now been associated with all steps of peroxisomal growth 
and division (Fig. 1, 2). Through oligomerisation and inter-
action with membrane lipids via N-terminal amphipathic 
helices, Pex11β acts as a membrane-shaping protein which 
remodels, deforms and elongates the peroxisomal membrane 
prior to fission (Opaliński et al. 2011; Yoshida et al. 2015, 
Su et al. 2018). Pex11β also interacts with the membrane 
adaptors Fis1 (fission protein 1) and Mff (mitochondrial 
fission factor) at the peroxisomal membrane, which recruit 
the dynamin-related fission GTPase Drp1, thus contribut-
ing to the assembly of the peroxisomal division machinery 
(reviewed in Koch and Brocard 2012; Itoyama et al. 2013; 
Schrader et al. 2016) (Fig. 1, 2). Furthermore, it has been 
revealed that Pex11β functions as a GTPase-activating pro-
tein (GAP) for Drp1 during peroxisomal fission (Williams 
et al. 2015). How peroxisomal membranes constrict prior to 
final membrane scission by Drp1 is still unclear; however, it 
is possible that Pex11β is also involved in constriction. For 
mitochondria, a role of the ER in membrane division has 
been revealed (Friedman et al. 2011; Lewis et al. 2016). If 
the same applies to peroxisomes is currently unknown. Our 
knowledge about key proteins in peroxisome division and 
multiplication has clearly increased, but it will be a chal-
lenge for upcoming years to understand their coordinated 
interplay and regulation.
An important discovery in the field was that peroxisomes 
and mitochondria share proteins of their division machinery, 
for example Fis1 (Koch et al. 2005), Mff (Gandre-Babbe and 
van der Bliek 2008), the ganglioside-induced differentiation-
associated protein GDAP1 (Huber et al. 2013), and Drp1 
(Li and Gould 2003; Koch et al. 2003) in mammals (Fig. 1). 
Sharing of division factors between peroxisomes and mito-
chondria has also been reported in other organisms, e.g. for 
the plant-specific division factor PMD1 (peroxisomal and 
mitochondrial division factor 1) (Aung and Hu 2011), and 
for the adaptors Mdv1 and Caf4 as well as the dynamin-
related GTPase Dnm1 in the yeast S. cerevisiae (Kuravi et al. 
2006; Motley et al. 2008) (Fig. 2). PMD1 has very recently 
been reported to influence peroxisome proliferation upon salt 
stress in Arabidopsis thaliana (Frick and Strader 2018). For 
reviews on peroxisome division and proliferation in plants 
and yeast, see Hu (2010) and Saraya et al. (2010). Sharing 
division components between peroxisomes and mitochon-
dria is seen as a common, evolutionarily conserved strat-
egy amongst mammals, fungi and plants, contributing to 
the “peroxisome–mitochondria connection”, which impacts 
on their cooperative functions and contribution to diseases, 
and promotes healthy lifespan (Waterham et al. 2007; Sham-
seldin et al. 2012; Schrader et al. 2015a, b; Koch et al. 2016; 
Weir et al. 2017a, b).
Meanwhile, several patients with defects in the peroxiso-
mal division/dynamic proteins Drp1, Mff and Pex11β have 
been identified (reviewed in Costello et al. 2018). Drp1 and 
Mff deficiencies usually impair both peroxisomal and mito-
chondrial division resulting in highly elongated organelles. 
Drp1 deficiency, the first disorder described with a defect in 
both mitochondrial and peroxisomal fission (Waterham et al. 
2007), combined clinical features of peroxisomal (dysmy-
elination, severity) and mitochondrial disorders (autosomal 
dominant optic atrophy, neuropathy). Genetic analysis of this 
first patient, who died only a few weeks after birth, revealed 
a heterozygous, dominant-negative missense mutation 
(Ala395Asp) in the middle domain of Drp1, which inhibits 
Drp1 oligomerization and subsequent function in membrane 
fission (Chang et al. 2010). Additional Drp1 patients, who 
presented with developmental delay, refractory epilepsy or 
infantile encephalopathy, were recently described (Yoon 
et al. 2016; Chao et al. 2016; Sheffer et al. 2016; Vanstone 
et al. 2016; Fahrner et al. 2016; Nasca et al. 2016; Zaha 
et al. 2016). Genetic analysis revealed (1) missense variants 
in the Drp1 middle (oligomerisation) domain (Gly362Asp, 
G350R, E379K) implying a dominant-negative mechanism, 
(2) recessive nonsense mutations leading to truncated unsta-
ble protein (Chao et al. 2016; Sheffer et al. 2016; Vanstone 
et al. 2016), or (3) the first dominantly inherited mutations 
in Drp1 affecting conserved amino acids within the Drp1 
GTPase domain (Gerber et al. 2017). The latter Drp1 mis-
sense mutations were linked to the blinding disease optic 
atrophy. However, whereas mitochondria were elongated in 
patient fibroblasts, peroxisome morphology appeared nor-
mal (Gerber et al. 2017). The first patients with Mff defi-
ciency due to loss-of-function mutations in the Mff gene 
were reported (Shamseldin et al. 2012; Koch et al. 2016). 
They presented with developmental delay, peripheral neu-
ropathy, optic atrophy, and Leigh-like encephalopathy. Mito-
chondria and peroxisomes are highly elongated in patient 
fibroblasts, due to a failure in organelle division. Of note, 
Mff was also identified as a key effector of energy-sensing 
adenosine monophosphate (AMP)-activated protein kinase 
(AMPK)-mediated mitochondrial fission (Toyama et al. 
2016). In contrast to the neurological features observed in 
Mff patients, Mff-deficient mice die as a result of severe 
dilated cardiomyopathy leading to heart failure, which is 
likely the result of mitochondrial defects (Chen et al. 2015). 
Whereas mitochondria and peroxisomes in Mff-deficient 
mouse embryonic fibroblasts were highly elongated, their 
length was not substantially altered in Mff-deficient mouse 
cardiomyocytes. However, an increased heterogeneity in 
mitochondrial shape and abundance was observed (Chen 
et al. 2015). This may indicate that peroxisomal (mitochon-
drial) morphology and division is affected in a cell type-
specific manner. A mathematical modelling approach was 
recently developed to explain and predict alterations in 
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peroxisome morphology and dynamics in health and disease 
conditions (Castro et al. 2018a, b).
Patients with a loss of Pex11β present with short stature, 
eye problems (congenital cataracts), progressive hearing 
loss and neurological defects (Ebberink et al. 2012; Taylor 
et al. 2017). Peroxisome number and morphology in patient 
fibroblasts are altered. However, similar to Drp1 and Mff 
deficiency, the metabolic functions of peroxisomes are not 
significantly affected. This is in contrast to the classical per-
oxisome biogenesis disorders (e.g. Zellweger syndrome) and 
can complicate diagnosis through metabolic biomarkers (e.g. 
VLCFA). It also suggests that the patients’ symptoms relate 
to defects in peroxisome dynamics and plasticity, highlight-
ing the importance of proper control of peroxisome abun-
dance and membrane dynamics for cellular function. Inter-
estingly, altered peroxisome abundance in Pex11β-deficient 
epidermal cells was recently reported to result in abnormal 
mitosis and organelle inheritance, thus affecting cell fate 
decisions (Asare et al. 2017).
Peroxisome motility and distribution: mysterious 
movers
Progress has also been made in the understanding of peroxi-
some motility and the role of the cytoskeleton in peroxisome 
dynamics and distribution. In baker’s yeast, peroxisomes move 
along actin filaments by recruiting the myosin V motor Myo2 
via the PMP Inp2 (Inheritance protein 2) (Fig. 2). This is cru-
cial for the transport of peroxisomes into the bud, and thus 
for peroxisome inheritance. For balanced distribution, Inp1, 
another inheritance protein, links peroxisomes to the periph-
eral ER, thus retaining some peroxisomes in the mother cell 
(reviewed in Knoblach and Rachubinski 2015, 2016). Plant 
cells also move peroxisomes via actin filaments and myosin 
motors (reviewed in Sparkes and Gao 2014). PMD1 which is 
required for NaCl-induced peroxisome division (see above) 
is also an actin-binding protein and may mediate the peroxi-
some–cytoskeleton connection in plants (Frick and Strader 
2018). In contrast, in mammalian cells peroxisomes move 
bidirectionally along microtubules, using both kinesin and 
dynein motors (reviewed in Schrader et al. 2003; Neuhaus 
et al. 2016). How microtubule motors are recruited to peroxi-
somes in mammalian cells was long unclear, but recently a role 
Fig. 3  Contact zones between peroxisomes and other organelles 
described in mammals and yeast species. Identified tethering com-
plexes and (hypothetical) associated functions are shown next to the 
symbolized interactions. a In mammalian species, peroxisome inter-
actions have been reported for the ER (Costello et al. 2017; Hua et al. 
2017), mitochondria (Neuspiel et  al. 2008; Braschi et  al. 2010; Fan 
et  al. 2016), lysosomes (Chu et  al. 2015), lipid droplets (Schrader 
2001; Valm et  al. 2017), peroxisomes themselves (Bonekamp et  al. 
2012) and the ER + mitochondria in triple contacts (Horner et  al. 
2015). b For yeasts, peroxisome interactions have been described 
for the plasma membrane (Shai et al. 2018), the ER (Knoblach et al. 
2013; Mast et  al. 2016), mitochondria (Mattiazzi Ušaj et  al. 2015; 
Shai et al. 2018), the vacuole (Shai et al. 2018), lipid droplets (Binns 
et al. 2006) and ER + mitochondria (Cohen et al. 2014). PO, peroxi-
somes; MITO, mitochondria; LD, lipid droplets
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for the mitochondrial Rho GTPase Miro1 was revealed (Castro 
et al. 2018a, b; Okumoto et al. 2018) (Fig. 1). Miro1, which 
was initially described as a mitochondrial membrane adaptor 
for kinesin, is also targeted to peroxisomes, contributing to 
peroxisome distribution and microtubule-dependent motility. 
Like Fis1, Mff, GDAP1, MAVS and AtPMD1, Miro1 is also 
a tail-anchored membrane adaptor, which is shared by mito-
chondria and peroxisomes (Costello et al. 2017a, b, c) (Fig. 1). 
Interestingly, Miro1-mediated pulling forces also contribute to 
peroxisome membrane elongation and proliferation in cellular 
models of peroxisome disease (Castro et al. 2018a, b). These 
observations in combination with a mathematical model of 
peroxisome dynamics now allow us to link the microtubule 
cytoskeleton and motor-mediated pulling forces to peroxisome 
formation by growth and division in mammalian cells (Cas-
tro et al. 2018a, b). As peroxisome elongation and division 
can still occur in the absence of microtubules, this link was 
controversial. However, it is suggested that independent, but 
cooperative mechanisms exist, and that motor forces support 
membrane dynamics by providing directionality. This is now 
in agreement with observations in yeast, where actin-based 
myosin-driven pulling forces cause peroxisome elongation and 
separation in dynamin mutants (Hoepfner et al. 2001; Nagotu 
et al. 2008). In line with these observations, it is also possible 
that mechanical forces can divide peroxisomes, as this was 
recently reported for mitochondria (Helle et al. 2017). In this 
scenario, Mff is suggested to act as a membrane-bound force 
sensor to recruit the fission machinery to mechanically strained 
mitochondrial sites.
Similar to mammalian cells, peroxisomes in filamentous 
fungi also move along microtubules (reviewed in Knoblach 
and Rachubinski 2016; Steinberg 2016; Salogiannis and 
Reck-Peterson 2017). However, instead of binding motor 
proteins directly, they interact with motile early endosomes 
(EEs) (Guimaraes et al. 2015). In A. nidulans this “hitch-
hiking” on EEs requires PxdA, an EE-bound linker protein, 
which mediates peroxisome–EE interaction (Salogian-
nis et al. 2016). In the corn smut fungus Ustilago maydis, 
constant EE motility also enhances the diffusive motions 
of peroxisomes, which is supposed to impact on local mix-
ing and organelle–organelle interactions (Lin et al. 2016). 
Mathematical modelling of various aspects of intracellular 
transport in the filamentous fungus U. maydis has revealed 
new insights into the spatial organization of peroxisomes and 
other organelles (Lin et al. 2016; Lin and Steinberg 2017). It 
showed that peroxisome mobility and mixing requires both, 
active diffusion and directed transport. These mechanisms 
ensure even distribution of peroxisomes and allow frequent 
interaction, which is important for proper cellular function.
Peroxisome–organelle interactions: the mysterious 
world of tethers
An emerging theme in cell biology is the cooperation, com-
munication and interaction between subcellular organelles, 
which often involve physical contacts via membrane con-
tact sites. Peroxisomes are not isolated entities in the cell 
but communicate and share signals, metabolites and pro-
teins with other compartments including the ER, mitochon-
dria, lipid droplets and lysosomes (for recent reviews see 
Schrader et al. 2015; Wanders et al. 2016; Shai et al. 2016; 
Yoboue et al. 2018; Castro et al. 2018) (Fig. 3). Investigating 
organelle interaction and identifying proteins that mediate 
organelle contacts is an active research area, which requires 
novel tools and techniques. For example, the use of multi-
spectral imaging allowed the simultaneous visualization of 
six organelles (including peroxisomes) and mapping of their 
interaction (Valm et al. 2017). Systematic mapping of con-
tact sites in baker’s yeast by a proximity detection method 
based on split fluorophores revealed new contacts between 
peroxisomes and the plasma membrane, as well as between 
peroxisomes and the vacuole (Shai et al. 2018) (Fig. 3). 
Furthermore, individual tethering functions for the yeast 
mitofusin Fzo1 and the PMP Pex34 in peroxisome–mito-
chondria contacts were revealed (Fig. 3). This study also 
demonstrated a physiological role for peroxisome–mitochon-
dria contacts in the β-oxidation of fatty acids, a process that 
requires metabolic cooperation between both organelles 
(for recent reviews on the peroxisome–mitochondria con-
nection see Schrader et al. 2015a, b; Wanders et al. 2016; 
Pascual-Ahuir et al. 2017; Fransen et al. 2017). In this con-
text it is of interest that in S. cerevisiae peroxisomes can 
be localized adjacent to a specific mitochondrial niche near 
the ER–mitochondria contact site, proximal to where the 
pyruvate dehydrogenase complex is found in the mitochon-
drial matrix, thus suggesting a three-way organelle junction. 
Peroxisomal Pex11 and mitochondrial Mdm34, one of the 
proteins creating the ER–mitochondria tether (ERMES), are 
supposed to mediate the peroxisome–mitochondria contact 
(Cohen et al. 2014) (Fig. 3). Comparable joined three-way 
organelle complexes between peroxisomes, chloroplasts 
and mitochondria have been observed in green cotyledon 
cells of A. thaliana upon exposure to light (Hayashi et al. 
2001). Pex10 and an unknown counterpart on the chloro-
plast are supposed as mediators of the interaction, which 
overtly serve to shuttle photosynthesis products through 
the photorespiratory pathway during photorespiration. To 
date, direct contacts between peroxisomes and mitochon-
dria in mammalian cells are not documented without any 
doubt. Yet, hormone-induced, controlled steroid hormone 
biosynthesis requires inter-organelle cooperation between 
peroxisomes and mitochondria. Using immunofluorescent 
staining and live-cell imaging, evidence was provided that 
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di-butyryl-cAMP treatment of MA-10 mouse tumor Leydig 
cells rapidly induces peroxisomes to approach mitochondria 
(Fan et al. 2016). The authors suggest that isoform A of the 
endogenous acyl-CoA binding protein ACBD2/ECI2, head 
to tail inserted into peroxisomes and mitochondria, may play 
a role in establishing a two-way communication between 
both organelles for supplying cholesterol used for steroid 
hormone biosynthesis.
Machine learning prediction approaches in combination 
with mutational analyses revealed new tail-anchored adaptor 
proteins at peroxisomes and other organelles (Costello et al. 
2017a, b, c) (Fig. 1). This then led to the molecular char-
acterisation of the first peroxisome–ER membrane contact 
sites in mammalian cells involving the peroxisomal acyl-
CoA-binding domain proteins ACBD5 and ACBD4, which 
interact via FFAT-like (two phenylalanines (FF) in an acidic 
tract) domains with ER-resident VAPA/B proteins, which are 
also tail-anchored membrane adaptors (Costello et al. 2017b, 
c; Hua et al. 2017) (Figs. 1, 3). The ACBD5–VAPA/B con-
tact plays a role in plasmalogen biosynthesis, which requires 
metabolic cooperation between peroxisomes and the ER 
(Hua et al. 2017; Herzog et al. 2017). Moreover, the peroxi-
some–ER contacts influence peroxisome motility providing 
a new role for a peroxisome–ER tether in the regulation of 
peroxisome movement and membrane dynamics in mamma-
lian cells (Costello et al. 2017; Hua et al. 2017; Castro et al. 
2018a, b) (Fig. 3). In addition, a role of peroxisome–ER 
contacts in lipid transfer for peroxisome membrane expan-
sion and biogenesis was revealed (Fig. 3). As discussed 
above, expansion and growth of the peroxisomal membrane 
is a prerequisite for division and proliferation. This requires 
lipids which are supposed to be provided by the ER in a 
non-vesicular pathway (Raychaudhuri and Prinz 2008; Cos-
tello et al. 2017). Defects in peroxisome division (e.g. due 
to loss of Mff or Drp1 function) result in highly elongated 
peroxisomes, suggesting a constant transfer of lipids from 
the ER to peroxisomes. Loss of peroxisome–ER interactions 
was shown to reduce membrane expansion supporting a role 
of peroxisome–ER contacts in lipid transfer for peroxisome 
biogenesis. To reveal how lipids are transferred is a chal-
lenging task for future studies. As approx. 70–80% of per-
oxisomes in cultured mammalian cells interact with the ER, 
ER-derived pre-peroxisomal vesicles may not have a major 
role in lipid transport to peroxisomes.
As a result of these studies, patients with mutations in 
ACBD5 have been identified, which suffer from retinal dys-
trophy and white matter disease (Yagita et al. 2017; Ferdi-
nandusse et al. 2017); mutations in VAPB have been linked 
to amyotrophic lateral sclerosis (Taylor et al. 2016). This 
may suggest possible links between loss of peroxisome 
contact sites and cell dysfunction (reviewed in Castro et al. 
2018).
Unveiling a hitherto undescribed organellar coopera-
tion, `tethers`, shared by peroxisomes and the lysosomal 
compartments mediating the intracellular routing of cho-
lesterol have been described (Du et al. 2015). Cholesterol 
is an essential determinant of membrane fluidity, permea-
bility and organization in animal cells (Chang et al. 2006). 
With the vast majority localized in the plasma membrane 
(Maxfield and Wüstner 2002), it originates from the ER 
via de novo synthesis (Horton et al. 2002; Kovacs et al. 
2002), and from lysosomes via receptor-mediated endocy-
tosis of plasma LDL (Brown and Goldstein 1986). It plays 
important roles in steroidogenesis, bile acid biosynthesis 
and signal transduction by regulatory oxysterols (Yeagle 
1988; Lingwood and Simons 2010), implying a dynamic 
intracellular routing. This raises the fundamental ques-
tion, `how is cholesterol transported from compartment 
to compartment`? Surprisingly, peroxisomes have been 
shown to play a critical part in the transport of free choles-
terol from lysosomes to the plasma membrane (Chu et al. 
2015). A so-far unrecognized contact between lysosomes 
and peroxisomes was observed, established at least in part 
by the binding of the integral lysosomal membrane protein 
synaptotagmin 7 to the lipid PI(4,5)P2 on the peroxiso-
mal membrane (Fig. 3). Notably, efficient formation of the 
tether required NPC1, which proved to be transient and 
cholesterol dependent. Disruption of critical peroxisomal 
genes led to an accumulation of cholesterol in lysosomes 
as it is observed in the Niemann–Pick disease type C 
(NPC). The latter is a fatal predominantly neurodegenera-
tive disorder (Carstea et al. 1997) caused by mutations in 
NPC1 and NPC2, which together mediate the transport of 
free cholesterol out of the lumen to the limiting membrane 
of lysosomes (Sleat et al. 2004). How cholesterol finally 
approaches the plasma membrane is still elusive. In any 
case, peroxisomes have apparently a pivotal role in the 
intracellular trafficking of cholesterol and its derivatives.
Dietary uptake, endogenous de novo synthesis, efflux 
and conversion of cholesterol to derivatives like bile acids, 
tightly regulate cellular cholesterol levels. An elaborate feed-
back system senses the actual concentration adjusting it by 
both trans- as well as post-transcriptional systems. Central 
to the transcriptional control are (1) the sterol regulating 
element-binding protein (SREBP) family; (2) the SREBP 
cleavage-activating protein (SCAP) which functions as a 
sterol sensor; (3) the Insigs (insulin-induced genes) which 
control SREBPs over a wide range of cholesterol concentra-
tions. The Insig–SCAP–SREBP network resides in the ER 
with its very low levels of sterols. In studies using a mouse 
model for Zellweger syndrome  (Pex2−/− mice), low levels of 
cholesterol in plasma and liver of the mice were observed. 
Moreover, the mice were unable to maintain normal choles-
terol homeostasis despite activation of the master regulator 
SREBP and increased activities of cholesterol biosynthetic 
Histochemistry and Cell Biology 
1 3
enzymes. Last but not least, the SREBP complex remained 
activated even after normalization of hepatic cholesterol in 
response to bile acid feeding (Faust and Kovacs 2014). In 
line with preceding studies (Kovacs et al. 2009), the authors 
suggest that peroxisome deficiency activates hepatic ER-
stress pathways leading to a dysregulation of the endogenous 
sterol-response mechanism.
Mysterious messengers: peroxisomes 
in signalling and antiviral defence
Importantly, peroxisomes cooperate in antiviral signalling 
and defence by means of the tail-anchored MAVS (mito-
chondrial antiviral signalling) proteins (Dixit et al. 2010; 
Kagan 2012) (Fig. 1). Thereby, peroxisomal MAVS rapidly 
induce expression of a subset of antiviral genes that curb 
viral replication, while the mitochondrial MAVS induce a 
sustained antiviral response. Interestingly, peroxisomes are 
also required for the engulfment of bacteria by Drosophila 
and mouse macrophages, and the resolution of bacterial 
infections by modulating the canonical innate immunity 
pathways through ROS and RNS signalling (Di Cara et al. 
2017). The role of peroxisomes was investigated in adult 
Drosophila flies and the related S2 cell line as well as 
in mice, in which consistently the key peroxins Pex5 and 
Pex7 had been impaired. A reduced capacity in respond-
ing to microbial pathogens, defects in immune signalling, 
and a reduced viability have been observed in flies and 
S2 cells, and a requirement for peroxisomes in microbe 
engulfment by the murine macrophages could be docu-
mented. Interpreting the findings related to the impaired 
expression of the peroxins, the authors suppose a compro-
mised phagocytosis of bacteria, defects in the reorganiza-
tion of the cytoskeleton required for forming phagosomes 
and proceeding phagocytosis, and a modulation in ROS/
RNS signalling to activate an immune response. It is 
tempting in line with the forgoing reports (e.g. Dixit et al. 
2010) to cede peroxisomes a critical subcellular hub in 
promoting innate immune responses.
HIV viruses are particularly successful in subverting 
host antiviral responses. It has recently become apparent 
that peroxisomes are part of these effective countermeas-
ures (Xu et  al. 2017). Specifically, HIV-infected cells 
express high levels of microRNAs, a subset of which are 
predicted to target peroxisome biogenesis factors (PEX2, 
PEX7, PEX11ß, PEX13) resulting in reduced numbers of 
peroxisomes. Interestingly, levels of these microRNAs 
proved to be elevated in brain tissues from HIV patients 
as well as HIV-infected macrophages. Thus, increasing 
the expression of microRNAs that down-regulate peroxi-
somes might be a novel mechanism to interfere with early 
antiviral signalling emanating from these organelles. The 
development of neurological disorders in AIDS patients 
might be attributed to this mechanism.
Reactive oxygen/nitrogen species (ROS/NOS) in con-
cert with other reactive molecules have emerged over the 
past decades as important regulators of many physiological 
and pathological processes, contributing to and completing 
superior regulating systems operating in a living organism. 
ROS/NOS serve as signalling messengers, mediating vari-
ous biological responses including gene expression, cell 
proliferation, angiogenesis, innate immunity, programmed 
cell death and senescence (Dowling and Simmons 2009; 
Scherz-Shouval and Elazar 2011). On the other hand, 
increased levels of these short-lived reactive molecules or 
any disturbance in ROS/NOS homeostasis can exert harm-
ful effects due to oxidative stress (e.g. Salmon et al. 2010).
In the past years, peroxisomes have been pointed out as 
key regulators in overall cellular lipid and ROS/NOS metab-
olism, thereby intimately interacting both functionally and 
physically with other cell organelles, in particular with mito-
chondria (Fransen et al. 2017). Plant peroxisomes have been 
shown to house principal enzymes involved in the generation 
of ROS/NOS, related to the defence against oxidative stress 
(Corpas et al. 2017). Seed germination in the dark requires 
enzymes catalysing β-oxidation and gluconeogenesis to con-
vert fatty acids into sugars, and the components of the ascor-
bate–glutathione cycle to protect oil bodies against oxidative 
damage caused by  H2O2 produced during the breakdown of 
the fatty acids (Eastmond 2007; Goepfert and Poirier 2007). 
In leaves, stomatal movement is highly regulated by external 
stimuli (light) as well as internal molecules (hormones). NO 
induces stomatal closure, and restricts the entry of patho-
genic microorganisms (Neill et al. 2008). Peroxisomal NO 
and ROS are involved in leaf senescence, characterized by 
a decrease in catalase activity and a down-regulation of 
NO generation (Corpas et al. 2004). In A. thaliana seed-
lings grown under salinity stress or exposed to cadmium, 
an increase in peroxisomal NO content has been reported 
(Corpas and Barroso 2014). In summary, these findings 
highlight the importance of peroxisomal NO metabolism 
under abiotic stress conditions in plants. ROS production 
in plant cells shows dramatic increases during senescence 
and under biotic and abiotic stress (Zentgraf 2007). Within 
this scenario,  H2O2 plays a key role. Ascorbate peroxidase 
is probably the most important enzyme scavenging  H2O2 
produced in chloroplasts, yet is also present in cytoplasm, 
peroxisomes and mitochondria (Narendra et al. 2006). In 
Arabidopsis different catalase isoforms are described with 
Cat3 levels varying substantially during the plant life span, 
increasing particularly in leaves of senescent plants (Zim-
mermann et al. 2006). Matching these variations, it could be 
demonstrated by in vivo imaging that peroxisomal  H2O2 in 
leaves is also modulated during the life cycle (Costa et al. 
2010). Interestingly, clear evidence could be provided for a 
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strict correlation between Cat3 expression levels and effec-
tive  H2O2 scavenging dependent on intra-peroxisomal  Ca2+. 
Apparently, activation of Cat3 caused by an increase of  Ca2+ 
inside peroxisomes represents a highly efficient cellular 
mechanism to strictly control  H2O2 levels.
It is widely accepted that an accumulation of senescent 
cells and accompanying secretions as well as the loss of 
stem cell renewal capacities contribute to tissue ageing 
(Collado et al. 2007). The existence of these cells in tis-
sues of ageing primates was confirmed about a decade 
ago (Herbig et al. 2006), and their elimination in a mouse 
model indeed delayed the appearance of age-related dis-
orders (Baker et al. 2011). Senescent cells have lost their 
ability to replicate, are enlarged, and express so-called 
senescence markers. Moreover, they are resistant to 
apoptosis and secrete bioactive molecules, e.g. cytokines 
(Giordano and Terlecky 2012). Ageing is considered a 
natural phenomenon in which cells enter into a senes-
cent stage to avoid transformation into cancerous cells 
(Campisi and Robert 2014). Multiple factors affect cellu-
lar ageing including shortening of telomeres, alteration of 
protein expression, defects in DNA repair machinery and 
accumulation of cellular ROS—in particular  H2O2—which 
are suggested a “primary mediator” of in vitro senescence 
and in vivo ageing (Lu and Finkel 2008). In view of their 
diverse metabolic functions, in particular their role both 
as source and sink of ROS in a cell, peroxisomes are a 
predestined hub in cellular ageing. Indeed, a plethora of 
studies employing cell lines of diverse origin, animals, 
and yeast cultures report on profound alterations in the 
biogenesis and proliferation of the organelle, in the rate 
of expression as well as location of peroxisomal enzymes 
engaged in ROS metabolism (catalase), and last but not 
least in the interaction with other cell organelles, particu-
larly mitochondria (Deori et al. 2018 and ref. therein). 
Consistently, they reveal that peroxisomes are critical con-
tributors to ageing, longevity and age-related disorders.
The free radical theory of ageing posits oxidative damage 
to macromolecules as a primary determinant of lifespan. In 
some cases, however, longevity is enhanced by the inac-
tivation of oxidative stress defences or is correlated with 
increased, rather than decreased ROS and oxidative dam-
age. Using S. cerevisiae, Mesquita et al. convincingly dem-
onstrated that caloric restriction or inactivation of catalase 
induces oxidative stress by  H2O2, nevertheless promoting 
longevity despite increased oxidative damage of macromol-
ecules (Mesquita et al. 2010). An induction of superoxide 
dismutase by  H2O2 reducing the levels of oxygen radicals 
was proposed to account for this surprising finding pointing 
to a hormesis effect of  H2O2 in promoting longevity.
Another regulatory effect of peroxisomal ROS with 
a profound impact on cellular growth was reported some 
years ago (Zhang et al. 2013). Two components (TSC1 
and TSC2) of the tuberous sclerosis complex (TSC) were 
found to localize to peroxisomes. In response to ROS both 
influence mTorC1, which upon diverse inputs (insulin, glu-
cose, amino acids) affects the switch between growth and 
autophagy. According to these observations, peroxisomes 
have an impact on the central regulator of cellular growth in 
mammalian tissues.
Type 2 diabetes is a complex disease accompanied by 
elevated levels of non-esterified fatty acids (NEFAs). The 
latter are known to disturb the function of β-cells and to 
induce loss of these cells, effects termed lipotoxicity. In a 
study employing primary rat islet cells as well as related cell 
lines, experimental evidence has been provided that NEFA-
induced β-cell lipotoxicity is intimately related to peroxiso-
mal metabolism of NEFAs (Elsner et al. 2011). Since the 
expression of  H2O2-inactivating catalase is virtually absent 
in peroxisomes of insulin-secreting β-cells (Lenzen et al. 
1996), the inactivation of  H2O2 generated in peroxisomes 
by the β-oxidation of NEFAs is severely impeded, explain-
ing the exceptional susceptibility of pancreatic β-cells to 
lipotoxicity.
Summarizing the findings on the functional plasticity of 
peroxisomes, we are overtly stepping from the view of a 
relict “fossil organelle” towards an extremely important one 
for optimum functioning of a cell. Despite great advances in 
unravelling its diverse contributions to the vitality-respective 
abiosis of cells, it is evident that peroxisomes will continue 
to emerge as critical contributors to these fundamental 
features.
News from the brain: unravelling 
the mysterious role of peroxisomes 
in the central nervous system (CNS)
One of the major hallmarks of peroxisomal inherited disor-
ders is the often severe neuropathological phenotype repre-
sented by developmental alterations in neuronal migration, 
a progressive demyelination of neurons or inflammatory 
activation of microglia (Berger et al. 2016). The signifi-
cance of peroxisomal metabolism for the maintenance of 
brain physiology is evident, but several open questions 
remain: (1) peroxisomes in different neural cell types and 
brain regions show heterogeneity (Ahlemeyer et al. 2007) 
pointing to different functions in the individual cell types 
which may contribute differently to the phenotype of per-
oxisomal disorders. (2) Differences in brain pathology of 
peroxisomal biogenesis disorders (PBDs) and the single 
enzyme deficiencies (SEDs) suggest that not only a single 
metabolic function of peroxisomes is responsible for dis-
ease pathogenesis. It remains to be clarified how the dis-
tinct metabolic pathways of peroxisomes and/or regulatory 
functions contribute to the development and maintenance 
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of the CNS. (3) Although the aetiology of various inherited 
peroxisomal disorders has been clarified, there is still sig-
nificant lack of information on the disease mechanism and 
active metabolites disturbing cellular physiology. (4) While 
alterations in mitochondria and the ER have been associ-
ated with the pathogenesis of important neurodegenerative 
diseases such as Huntington’s, Parkinson’s and Alzheimer’s 
disease (Xiang et al. 2017; Martinez-Vicente 2017), a pos-
sible contribution of peroxisomes to the pathology of these 
diseases is largely unexplored. Since our last review several 
of these open questions have been addressed in a variety of 
studies summarized below.
To evaluate the role of peroxisomes for maintaining brain 
pathology, the groups of Nave and Baes created several con-
ditional mouse knockout strains deleting the peroxisomal 
import receptor Pex5 from the liver, all neural cell types, 
oligodendrocytes, astrocytes and projection neurons, respec-
tively (Krysko et al. 2007; Kassmann et al. 2007; Bottelbergs 
et al. 2010). While disruption of peroxisomal functions in 
liver resulted in the most severe phenotype, showing devel-
opmental changes in brain architecture, deletion of PEX5 
from all neural cells exhibited only a developmental delay 
in neural cell migration and primarily induced degenera-
tive alterations in axons in adulthood (Krysko et al. 2007; 
Hulshagen et al. 2008). Comparably, brain-specific condi-
tional  Pex13−/− mice exhibit a developmental phenotype 
with delayed formation of cerebellar layers but additionally 
showed abnormal Purkinje cell differentiation accompanied 
by a reactive gliosis (Müller et al. 2011). At later stages, 
these knockout mice showed a degeneration of serotonergic 
neurons in Raphe nuclei (Rahim et al. 2014). The neurons 
exhibited abnormal axonal swellings which were accom-
panied by an activation of astro- and microglia indicating 
inflammatory processes. In addition to functions in the CNS 
locomotor system, serotonergic Raphe neurons contribute 
to neuro-vegetative control and emotional behaviour (Lucki 
1998), brain functions which have hitherto not been investi-
gated in the light of peroxisomal disorders.
With regard to the importance of peroxisomal metabo-
lism in individual neural cell types, specific deletion of per-
oxisomal function in oligodendrocytes appeared to be most 
crucial for maintaining brain homeostasis. In contrast, condi-
tional astroglia- and projection neuron-specific  Pex5−/− mice 
were largely asymptomatic (Kassmann et al. 2007; Bottel-
bergs et al. 2010). Remarkably, peroxisomes are heteroge-
neously distributed inside neurons and are largely absent 
from the axonal compartment of long projection neurons 
(Kassmann et al. 2007, 2011), which might explain why the 
corresponding knockouts did not induce axonal degenera-
tion. By contrast, peroxisomes are highly abundant in the 
myelin-forming oligodendrocytes surrounding the axons. 
To analyse the functional cooperation between peroxi-
somes in myelinating cells and axons, the authors studied a 
conditional oligodendrocyte-specific Pex5 knockout strain 
(Cnp–Pex5−/−). In the peripheral Schwann cell-associated 
nerves, which are not compromised by immune-mediated 
injury and dysmyelination like neurons in the CNS, vesicu-
lar accumulations were observed in swellings close to the 
nodes of Ranvier (Kassmann et al. 2011). Such axonal swell-
ings are a typical phenomenon preceding axonal degenera-
tion (Griffiths et al. 1998). In line with electrophysiological 
dysfunctions, these axons showed an abnormal internodal 
localization of normally juxtaparanodally positioned mem-
brane proteins (Kv1 channels, CASPR2, TAG-1) (Kleinecke 
et al. 2017). In healthy nerves, GD1 gangliosides form par-
anodal lipid raft-like structures required for correct mem-
brane protein positioning. In the Cnp–Pex5−/− mice, how-
ever, the myelinated nerves exhibited dispersed internodal 
GD1 gangliosides with increased acyl chain length. These 
internodal GD1 clusters partially colocalized with lysosomes 
suggesting that the accumulating gangliosides could not be 
degraded. As peroxisomes were found in close association 
with these lysosomal accumulations, the authors concluded 
that the defect in peroxisomal β-oxidation precludes the 
degradation of VLCFA incorporated into the gangliosides. 
Accordingly, gangliosides accumulate in lysosomes and cell 
membranes, compromising axonal transport processes, posi-
tioning of membrane proteins and ultimately nerve electro-
physiology (Kleinecke et al. 2017).
While knockout of Pex5 disrupts all major peroxisomal 
pathways, it remains to be clarified how individual meta-
bolic peroxisomal functions contribute to the brain pathol-
ogy of patients with peroxisomal disorders. Peroxisomal 
β-oxidation is responsible for the degradation of straight 
VCLFA, branched-chain fatty acids and cholesteryl ester 
side chains. Therefore, it is important to identify, which 
metabolites may target the brain in peroxisomal disorders. 
In addition to the most prevalent disorder, X-linked adre-
noleukodystrophy (X-ALD), which is evoked by mutations 
in the peroxisomal fatty acid transporter ABCD1 (Fig. 1), 
important SEDs with a severe brain pathology are caused by 
mutations in the genes of acyl-CoA oxidase 1 (ACOX1) and 
the multifunctional protein 2 (MFP2, encoded by HSD17B4) 
(Berger et al. 2016). These enzymes catalyse the first and 
second steps in peroxisomal β-oxidation, respectively. More-
over, isoforms with different substrate specificities exist for 
both proteins. ACOX1 preferentially degrades straight chain 
fatty acids, while ACOX2 and ACOX3 handle branched-
chain fatty acids and cleave the side chains of cholesteryl 
esters in the pathway of bile acid synthesis (Van Veldhoven 
2010). Recently, patients with a mutated, non-functional 
ACOX2 have been identified who show markedly elevated 
levels of C27 bile acid intermediates (Vilarinho et al. 2016; 
Monte et al. 2017). The patients suffer primarily from a liver 
pathology, whereas neurological functions are only mildly 
compromised (Vilarinho et al. 2016). Branched-chain fatty 
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acid levels are not altered in ACOX2 patients, implying a 
functional complementation by ACOX3 (Ferdinandusse 
et al. 2018). By contrast, ACOX1 patients exhibit a mild 
Zellweger-like pathology with visual and hearing impair-
ment, and degenerations in cerebral and cerebellar white 
matter tracts resulting in psychomotor retardation and pro-
gressive loss of motor achievements (Ferdinandusse et al. 
2007). Thus, accumulation of straight VCLFAs might be 
especially toxic for the human brain. However, correspond-
ing  ACOX1−/− mice do not develop a CNS phenotype but 
rather a severe liver pathology (Fan et al. 1998). Hence, 
other mouse models were required to investigate the role of 
peroxisomal β-oxidation in the brain pathology of peroxi-
some disorders.
MFP2 (also termed D-bifunctional protein) cataly-
ses the second and third steps in peroxisomal β-oxidation 
and processes most of the metabolites emerging from step 
one. MFP2-deficient patients suffer from a severe brain 
pathology including neuronal migration defects and a pro-
gressive demyelination. With MFP1 (L-PBE), an alterna-
tive enzyme exists, which might compensate for the loss 
in MFP2. However,  MFP1−/− mice show no reduction in 
peroxisomal β-oxidation or a pathologic phenotype. In 
contrast,  MFP2−/− mice accumulate VLCFA, branched-
chain fatty acids and bile acid intermediates in plasma 
and tissues and are, hence, a good model for a generally 
disrupted peroxisomal β-oxidation pathway (Baes et al. 
2000). These mice show none of the developmental altera-
tions observed in human MFP2 patients, but like humans 
develop a severe, progressive neuropathology exhibiting the 
first signs of dyskinesia before the age of 1 month, show 
a profound inflammatory pathology and usually die at an 
age of around 6 months (Huyghe et al. 2006). Liver peroxi-
somes contribute significantly to the maintenance of brain 
lipid homeostasis, and accordingly a liver-specific MFP2 
knockout mouse developed a most severe brain phenotype 
(Krysko et al. 2007). It remained to be clarified, if the indi-
vidual β-oxidation in the main neuronal cell types also con-
tributes to the brain pathology. To this end, the Baes group 
established a nestin–MFP2−/− strain ablating peroxisomal 
β-oxidation in all neural cell types (nestin–MFP2−/−), an 
oligodendrocyte-specific MFP2 deletion (Cnp–MFP2−/−) 
and a Purkinje cell-specific deletion (L7–MFP2−/−) strain 
(Verheijden et al. 2013; De Munter et al. 2018). The nes-
tin–MFP2−/− mouse showed the most severe pathology 
establishing a locomotor phenotype comparable to the con-
stitutive MFP2 knockout. Early on the mice develop a pro-
gressive ataxia, kyphosis and abnormal limb positioning; 
however, they also exhibit a prolonged life and generally less 
severely altered neurologic parameters than the full knockout 
(Verheijden et al. 2013; Beckers et al. 2018). Morphologi-
cally, the neural phenotype was accompanied by cerebellar 
atrophy with early-onset axonal swellings and a dramatic 
reduction in Purkinje cells at an age of 1 year. Both, the total 
and the neural MFP2 knockouts developed an inflammatory 
brain phenotype, which, however, differed significantly in 
its severity (Verheijden et al. 2013; Beckers et al. 2018). 
The authors concluded that the initial primary neuronal 
deficits are exaggerated by the strong microglia activation 
only found in the constitutive  MFP2−/− mice (Beckers et al. 
2018). Unexpectedly, the deletion of MFP2 from oligoden-
drocytes (Cnp–Pex5−/−) resulted in a rather mild phenotype 
without signs of ataxia and inflammatory responses before 
12 months of age. Nevertheless, peripheral neurons exhib-
ited the same mislocalization of juxtaparanodal membrane 
proteins observed for the Cnp–Pex5−/− mice indicating that 
the accumulation of peroxisomal β-oxidation metabolites 
induced alterations at the molecular level (Kleinecke et al. 
2017). In the light of the severe neuropathological phenotype 
of the oligodendrocyte-specific  Pex5−/− mice, these find-
ings are intriguing and imply that the lack of β-oxidation in 
cerebellar oligodendrocytes can be compensated by the per-
oxisomes in the remaining neural cell types. In contrast, such 
compensation is not possible for the Purkinje cell-specific 
deletion in the correspondent L7–MFP2−/− mice. This strain 
developed symptoms of ataxia already at the age of 6 months 
and showed a significant decline in Purkinje cell numbers at 
later stages (De Munter et al. 2018). According to these find-
ings, the role of peroxisomal metabolism in the CNS appears 
to be more complex than previously anticipated. Obviously, 
the significance of peroxisomes cannot be merely associated 
with the individual neural cell types. Rather, peroxisomes in 
neurons, astrocytes and oligodendrocytes appear to perform 
locally distinct functions that are of differing importance in 
individual CNS areas.
Peroxisomal β-oxidation is also compromised in X-ALD, 
since the mutation of the correspondent ABC transporter 
ABCD1 disrupts the import of VLCFAs into peroxisomes 
(Engelen et al. 2014) (Fig. 1). However, it remains unclear 
how the accumulating VLCFAs could mechanistically 
induce harmful alterations in the brain tissue. Elevated lipid 
peroxidation products have been found in X-ALD patient 
plasma samples suggesting that oxidative stress might be 
involved in the pathogenesis (Nury et al. 2017). Findings 
from  ABCD1−/− human fibroblasts and cultured neural 
mouse cells revealed an enhanced generation of ROS upon 
VLCFA exposure suggesting that lipid-induced oxidative 
damage might directly contribute to the neuropathological 
alterations (Fourcade et al. 2008; Hein et al. 2008; Kruska 
et al. 2015). Increased incorporation of VLCFAs into the 
phospholipids of the inner mitochondrial membrane might 
destabilize OXPHOS complexes inducing electron leakage 
and ROS production, finally compromising cell physiology 
(López-Erauskin et al. 2013; Fourcade et al. 2014). How-
ever, disease severity did not correlate with VLCFA eleva-
tion in the different conditional  MFP2−/− strains (Verheijden 
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et al. 2013, 2014). Thus, accumulation of VLCFAs might 
not be mainly responsible for the ROS-induced and inflam-
matory pathology observed in many peroxisomal disorders. 
Similar observations have also been reported for the differ-
ent  Pex5−/− mouse strains (Bottelbergs et al. 2010). While 
these data might question a simple dose–response correla-
tion between accumulating VLCFAs, mitochondrial ROS 
production and the cytopathological alterations in the brain 
of peroxisome disorder patients, the relation between peroxi-
somal dysfunction and changes in the mitochondrial redox 
balance remain evident. Inhibition of peroxisomal catalase 
in mouse embryonic fibroblasts induced changes in the mito-
chondrial redox equilibrium (Rahim et al. 2016). Therefore, 
dysregulation of peroxisomal lipid metabolism and ROS 
production might directly target mitochondria in the brain in 
peroxisome disorders (Rahim et al. 2016). Hence, while we 
increasingly understand the tissue pathology in peroxisomal 
β-oxidation disorders, one of the future challenges will be 
to decipher active metabolites, signalling systems and cyto-
logical alterations, which induce the severe brain pathology.
Myelin sheaths contain comparatively high concentra-
tions of plasmalogens/ether lipids synthesized in peroxi-
somes (Wanders and Poll-The 2017). Thus, it is not sur-
prising that a lack in ether lipid synthesis induces CNS 
pathology. The peroxisomal disorder rhizomelic chondro-
dysplasia punctata (RCDP) is caused by a disrupted ether 
lipid synthesis pathway. RCDP types 2–4 are peroxiso-
mal SEDs which are caused by mutations in the genes for 
dihydroxyacetone phosphate acyltransferase (GNPAT), 
alkyl-dihydroxyacetone phosphate synthase (ADHAPS) 
and fatty acyl-CoA reductase 1 (FAR1) (Dorninger et al. 
2017) (Fig. 1). With respect to the CNS pathology, RCDPs 
are characterized by myelination deficits, which result in 
enlarged ventricles and subarachnoidal spaces, as well as 
cerebellar atrophy (Dorninger et al. 2017). To analyse the 
molecular pathogenesis, two mouse models with a deletion 
in GNPAT and ADHAPS have been generated (Rodemer 
et al. 2003; Liegel et al. 2014).  GNPAT−/− mice develop 
neuropathological symptoms typical for RDCP such as a 
general reduction in hemisphere size, foliation defects of 
the cerebellum or a reduced myelination in the CNS white 
matter (Teigler et al. 2009). At the subcellular level, the mice 
show changes in Purkinje cells, like alterations in the synap-
tic innervation pattern from parallel and climbing fibres in 
dendrites as well as axonal swellings, which are paralleled 
by a disorganization in paranodal membrane proteins (Tei-
gler et al. 2009). Berger and coworkers investigated the influ-
ence of the ether lipid deficiency on presynaptic functions 
(Brodde et al. 2012). In parallel to a reduced  Ca2+-dependent 
neurotransmitter release the authors report a reduction in 
the respiratory capacity of synaptic mitochondria. The lack 
of plasmalogens in mitochondrial membranes might dis-
turb OXPHOS complexes and thus ATP generation by the 
mitochondrial electron transport chain. Since release and 
regeneration of synaptic vesicles are ATP-dependent pro-
cesses, mitochondrial dysfunction would eventually com-
promise synaptic transmitter release. In addition to the CNS 
pathology,  GNPAT−/− mice exhibit impaired axonal sorting 
and myelination in PNS sciatic nerves, which were ascribed 
to a dysregulation in p-AKT/GSK3β signalling in Schwann 
cells (da Silva et al. 2014; Hossain et al. 2017). Remarkably, 
GSK3β activity was reported to modulate Schwann cell dif-
ferentiation and initiation of myelination (Ogata et al. 2004), 
which might explain the myelination defects observed in the 
 GNPAT−/− mice.
As documented by the brain pathology in both 
β-oxidation as well as plasmalogen deficiencies, correct 
lipid homeostasis appears to be a crucial factor for brain 
physiology. During the last years, our understanding of the 
cytopathological alterations observed in the brain in peroxi-
somal disorders revealed that different cell types in different 
brain areas may contribute to disease pathogenesis. Moreo-
ver, we gained important knowledge on the distinct pathol-
ogy of individual SEDs. However, our understanding of the 
underlying molecular mechanisms leading from metabolic 
changes to the severe cytological alterations in the brain is 
still scarce and requires future research.
In addition to the developments in the field of peroxi-
somal disorders, peroxisome alterations have been recently 
associated with the pathogenesis of more widespread neu-
rological disorders (Berger et al. 2016). Increased VLCFAs 
as well as decreased plasmalogen concentrations were 
observed in cortical brain regions of advanced Alzheimer 
patients (Kou et al. 2011). The decrease in plasmalogens in 
Alzheimer patients and respective Alzheimer mouse models 
was further corroborated by more recent studies (Dorninger 
et al. 2017). Moreover, inhibition of peroxisomal β-oxidation 
was reported to increase the amount of Aβ generation in rat 
brain (Shi et al. 2012). These findings could indicate that a 
dysregulation in peroxisomal lipid metabolism might con-
tribute to Alzheimer pathogenesis.
Organelle transport defects are a common observation 
in neurodegenerative diseases as cellular transport systems 
have to ensure correct organelle distribution and removal 
inside the highly polarized neurons (De Vos and Hafezparast 
2017). Increased peroxisome volume densities were detected 
in the somata of neurons from patients with a pronounced 
Alzheimer pathology. In contrast, peroxisomes were absent 
in their neuronal processes when these were positive for the 
Alzheimer pre-tangle marker-phosphorylated tau (Kou et al. 
2011). Thus, efficient peroxisome transport between neurites 
and somata might be compromised in Alzheimer-affected 
neurons at an early stage in neuronal degeneration.
Peroxisome alterations were also reported in transgenic 
mouse models for Alzheimer’s disease (Cimini et al. 2009; 
Fanelli et al. 2013). However, it remains to be determined if 
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the changes in peroxisome metabolites are a secondary phe-
nomenon or play a causative role in the disease pathogen-
esis. In either case, the changes in the neuronal lipid com-
position might aggravate disease progression and thereby 
contribute to Alzheimer pathology.
While there are still limited amount of data on the per-
oxisome contribution in Alzheimer disease, first studies 
targeting peroxisomes for therapeutic issues have already 
been performed. Treatment with peroxisome prolifera-
tors was reported to mitigate spatial memory impairment, 
synaptic failure, and neurodegeneration in transgenic Alz-
heimer model mice (Inestrosa et al. 2013). However, as 
the transcriptional response to peroxisome proliferators 
includes numerous non-peroxisomal genes, further stud-
ies are required to substantiate that a specific stimulation 
of peroxisomal functions was responsible for the observed 
effects. Furthermore, oral substitution therapy has been con-
sidered as a therapy to restore normal plasmalogen levels 
in patients. Oral administration of purified scallop-derived 
plasmalogen was reported to improve cognitive functions 
in mild Alzheimer patients (Fujino et al. 2017). However, 
systematic animal studies imply that plasmalogens and their 
respective precursors do not efficiently cross the blood–brain 
barrier and are not incorporated into the CNS (Dorninger 
et al. 2018). Therefore, until further proof is provided, the 
value of an oral plasmalogen replacement therapy should be 
regarded with great caution.
In Parkinson’s disease, the presynaptic protein 
α-synuclein aggregates to form intracellular, insoluble, 
filamentous Lewy bodies, a cytopathological hallmark of 
the disease (Spillantini et al. 1997). Before Lewy body for-
mation, several posttranslational modifications like phos-
phorylation accumulate in α-synuclein and are regarded as 
early events in Parkinson pathology (Barrett and Timothy 
Greenamyre 2015). Interestingly,  Pex2−/−,  Pex5−/−, and 
 Pex13−/− mouse models exhibit increased α-synuclein phos-
phorylation, oligomerization and inclusion body formation 
(Yakunin et al. 2010). Long-chained, unsaturated fatty acids 
have been described as inducing factors for α-synuclein 
aggregation (Sharon et al. 2003; Assayag et al. 2007). In this 
regard, the accumulation of polyunsaturated long-chain fatty 
acids in Pex-deficient mutants might suggest a link between 
peroxisome dysfunction and Parkinson’s disease (Yakunin 
et al. 2010).
Compromised peroxisome physiology was recently 
described in the brain grey matter from multiple sclerosis 
(MS) patients using ABCD3 immunocytochemistry and 
gene expression analysis (Gray et al. 2014). In parallel, 
the authors observed elevated VLCFA concentrations in 
the affected brain regions suggesting a decline in peroxiso-
mal metabolism. In line with these observations, decreased 
enzyme activities and gene expression for peroxisomal pro-
teins were also reported in the CNS of a mouse model for MS 
with inflammatory autoimmune encephalomyelitis (Singh 
et al. 2004). Hence, peroxisome abundance might decrease 
during MS progression and activation of peroxisome bio-
genesis might be favourable in MS and other demyelinating 
disorders. Statins, in addition to their cholesterol-lowering 
effect, possess anti-inflammatory and immune-modulatory 
activities (Stanislaus et al. 2002; Vollmer et al. 2004). These 
responses are mediated by induction of PPARα/γ signalling 
pathways thus inducing peroxisome proliferation (Paintlia 
et al. 2013). However, statin therapy had only limited effi-
cacy on the CNS in MS (Pihl-Jensen et al. 2015). The AMPK 
activator 5-aminoimidazole-4-carboxamide ribonucleotide 
(AICAR) was also reported to reduce pro-inflammatory and 
immune responses in experimental autoimmune encephalo-
myelitis (Nath et al. 2009). A combined administration of 
the statin lovastatin and AICAR to autoimmune encephalo-
myelitis mice alleviated inflammation-induced dysfunction 
of mitochondria and peroxisomes as well as demyelination. 
Thus, restoring peroxisome function might be beneficial for 
MS disease prognosis (Singh et al. 2018).
Ischemic stroke is one of the major causes of death in 
modern societies. Understanding neuroprotective mecha-
nisms associated with cerebral ischemia is a prerequisite 
for the development of future therapeutic inventions. In 
mice, peroxisome proliferation was observed after focal 
cerebral ischemia induced by middle cerebral artery occlu-
sion suggesting a protective response (Young et al. 2015). 
For mechanistic studies, the authors induced ischemic injury 
in cortical neuron cultures by oxygen–glucose deprivation, 
and similar to the in vivo situation, neurons responded with 
peroxisome proliferation. When peroxisome division was 
impeded by Drp1-knockdown or when catalase activity was 
inhibited with 3-amino-1,2,4-triazole, increased neuronal 
cell death was observed in response to the ischemic insult. 
In contrast, administration of PPARα agonists had a protec-
tive effect on neuron survival rates (Young et al. 2015). The 
authors concluded that peroxisomes might exhibit protec-
tive functions against oxidative or metabolic stress induced 
after ischemia–reperfusion injury which might be targeted 
as therapy for neuroprotection after stroke.
In summary, the current literature implies that peroxi-
some abundance and metabolism play a role in a variety of 
pathologic states of the brain; however, it remains unclear 
if these peroxisome alterations primarily contribute to the 
pathogenesis of the disease described above or if they are 
secondary changes associated with a general decline in cel-
lular functions during disease progression. Therefore, fur-
ther studies are required, which systematically analyse per-
oxisome alterations at different disease stages, especially to 
unravel if therapeutic strategies targeting peroxisomes might 
be relevant to combat disease progression.
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Peroxisomes in the auditory system: 
mysterious hearing loss
Progressive hearing loss is one of the typical pathologies 
associated with inherited peroxisomal disorders (Braverman 
et al. 2016), thus pointing to an important functional role of 
peroxisomes in the auditory system. Pejvakin (Persian word 
for echo)-deficient humans and mice show a striking hyper-
vulnerability towards sound exposure.  Pejvakin−/− mice 
show features of marked oxidative stress and impaired anti-
oxidant defences in hair cells and cochlear ganglion neurons 
(Delmaghani et al. 2015). Subcellular localization studies 
with an antibody raised against the C-terminal region of 
pejvakin showed that endogenous pejvakin localizes to 
peroxisomes of inner ear hair cells, and  pejvakin−/− mice 
revealed peroxisome abnormalities in shape and localization 
after onset of hearing (Delmaghani et al. 2015). Expression 
of wild-type and mutant pejvakin resulted in increased or 
decreased peroxisome proliferation suggesting that pej-
vakin is involved in peroxisome biogenesis. In line with 
these findings, peroxisome proliferation was observed in 
inner and outer hair cells as well as dendrites of primary 
auditory neurons in response to sound exposure, whereas 
 pejvakin−/− mice exhibited decreased peroxisome num-
bers (Delmaghani et al. 2015). A more recent publication, 
however, doubted the peroxisomal localization of pejvakin 
(Kazmierczak et al. 2017). No colocalization of expressed 
pejvakin and the peroxisomal membrane marker PMP70 
was observed in HeLa cells using three different polyclonal 
antibodies designed against alternative pejvakin peptide 
sequences. Likewise, expression of pejvakin in inner hair 
cells did not result in a peroxisomal staining but selectively 
localized to stereociliary rootlets (Kazmierczak et al. 2017). 
Thus, while there is some evidence that peroxisomes react to 
sound exposure, potentially to counteract intracellular ROS 
generation, the role of pejvakin in peroxisome physiology 
remains uncertain.
Peroxisomes and cancer: a mysterious 
connection
Cancer cells face a completely different microenvironment 
than normal cells and have therefore to adapt their cellu-
lar metabolism to the hypoxic and hypo-nutrient condi-
tions in a tumor (Yoshida 2015). This process of metabolic 
reprogramming is considered one of the major hallmarks 
of cancer and in addition to changes in glucose and amino 
acid metabolism, alterations in lipid metabolism have been 
reported (Ghaffari et al. 2015). Moreover, dysregulations in 
cellular redox homeostasis can not only be pro-tumorigenic 
but also lead to resistance in tumor chemotherapy (Glasauer 
and Chandel 2014). Mitochondria have been considered one 
of the key organelles for these alterations in metabolism and 
redox homeostasis (Valcarcel-Jimenez et al. 2017; Ježek 
et al. 2018) and as mitochondrial and peroxisomal functions 
are closely linked (Schrader et al. 2015a, b), peroxisome 
physiology might also be relevant in the process of the tran-
sition of somatic into tumor cells.
Peroxisomes, housing a variety of oxidases, are potent 
 H2O2 producers and an imbalance in  H2O2 generation and 
degradation during the PPARα-mediated induction of 
peroxisomal fatty acid β-oxidation has been linked to the 
occurrence of liver tumors during chronic exposure to per-
oxisome proliferating drugs (Yu et al. 2003). Nevertheless, 
studies investigating the role of peroxisomes in spontane-
ously occurring tumor tissue remain limited. In a significant 
number of neoplastic tissues investigated, peroxisomal func-
tion appears to decline when compared to unaffected tissue. 
A reduced number of peroxisomes was observed in colon 
carcinomas using electron microscopy to detect catalase by 
alkaline DAB staining (Cablé et al. 1992). These data were 
corroborated by several publications reporting reduced per-
oxisomal protein abundance (catalase, ABCD3, ACOX1, 
PXMP2) or enzymatic activities (catalase, D-amino acid 
oxidase, polyamine oxidase, peroxisomal β-oxidation) in 
colon tumor tissue, implying an overall reduction of per-
oxisome abundance and function in the neoplastic tissue 
(Baur and Wendel 1980; Cablé et al. 1992; Keller et al. 
1993; Lauer et al. 1999). Likewise, a reduction in peroxi-
somal enzyme activities or protein amounts was reported in 
breast and hepatocellular carcinomas, respectively (Keller 
et al. 1993; Litwin et al. 1999). Interestingly, Lauer et al. 
(1999) observed increased mRNA levels of the correspond-
ent enzymes suggesting an imbalance in the turnover of 
peroxisomes which could be explained by incompetence 
in peroxisome biogenesis or increased rates of peroxisome 
degradation (pexophagy). However, conflicting data were 
published in a more recent study, which reports that per-
oxisomes are indispensable for the survival of liver cancer 
cells (Cai et al. 2018). As previous publications observed an 
up-regulation of Pex2 at the mRNA level in hepatic carcino-
mas (Chen et al. 2002; Wurmbach et al. 2007), Cai and col-
leagues silenced Pex2 by RNAi in hepatocellular carcinoma 
xenografts and reported significantly reduced tumor growth 
in response to the treatment. Furthermore, the authors report 
that the loss in peroxisome function leads to increased ROS 
levels by mislocalization of catalase to the cytosol. Sub-
sequent ER stress in the tumor cells would result in sup-
pression of mTORC1 signalling and elevation of autophagy 
ultimately leading to cell death (Cai et al. 2018). Contradict-
ing these interpretations, recent publications showed that 
a reduced catalase import rate is a cellular mechanism to 
protect cells from redox stress (Fujiki et al. 2017; Walton 
 Histochemistry and Cell Biology
1 3
et al. 2017). Recently published data on the potential role 
of ACOX1, the rate limiting and  H2O2-generating oxi-
dase in peroxisomal β-oxidation, in hepatocellular tumors 
underlines the complexity in understanding peroxisomal 
function in hepatocarcinogenesis (Chen et al. 2018). In this 
study, ACOX1 enzyme activity was found to be decreased 
by SIRT5-dependent lysine de-succinylation. After SIRT5 
knockdown, the authors consequently observed an increase 
in intracellular  H2O2 levels. Interestingly, the authors 
report that while ACOX1 protein levels were comparable 
or slightly reduced if compared to surrounding liver tis-
sue, ACOX1 activity was elevated, and SIRT5 expression 
decreased in most of the tumor samples. According to these 
findings increased ACOX1 succinylation might lead to 
excess  H2O2 generation in the tumor cells thereby promot-
ing the transformation of healthy into tumor cells.
In the healthy kidney, peroxisomes are most numerous 
in the epithelial cells of the proximal tubule (Islinger et al. 
2010a, b). In renal clear cell tumors, which recapitulate the 
tissue from proximal tubules (Prasad et al. 2007), however, 
peroxisomes were reported to be absent according to alka-
line DAB and immunofluorescence detection of catalase 
(Frederiks et al. 2010). In agreement with this observation, 
decreased catalase activities were found in renal tumors 
(Pljesa-Ercegovac et al. 2008). The hypoxia-inducible tran-
scription factor Hif2a has been recently shown to promote 
peroxisome degradation via autophagy (Walter et al. 2014). 
Remarkably, the authors showed that Hif2a levels negatively 
correlated with the abundance of peroxisomes in renal clear 
cell carcinoma, suggesting that its induction in a hypoxic 
tumor environment depletes peroxisomes by enhanced pex-
ophagy rates. Nevertheless, as all current findings on peroxi-
some abundance in renal tumors rely on catalase detection, 
future studies applying additional peroxisome markers have 
to verify a decrease in peroxisome abundance. When sum-
marized, these publications imply that a disruption of the 
peroxisomal compartment could be a major general hallmark 
in cancer biology. A reduction in peroxisomes might lead 
to local alterations in membrane lipid composition thereby 
altering the integration of neoplastic cells into the surround-
ing tissue. In addition, the loss of peroxisomes might desta-
bilize the intracellular ROS equilibrium and lead to locally 
elevated toxic, and partially oxidized VLCFA metabolites. 
In this respect, it is worthwhile to note that the latter were 
hypothesized to induce an ER-stress response in ACOX1 
knockout mice, which may eventually trigger the formation 
of liver tumors, which are regularly observed in this mouse 
line (Huang et al. 2011).
While the publications described above point to a general 
loss of peroxisome function during tumor progression, find-
ings from prostate cancer tissue implement a more complex 
role of peroxisomes in the maintenance of tumor growth. 
The peroxisomal α-methylacyl-CoA racemase (AMACR) 
expression was found to be highly elevated in tissue from 
prostate carcinoma if compared to benign prostate tissue 
(Jiang et al. 2001). Since this initial publication, numer-
ous studies have confirmed elevated levels of AMACR as 
a reliable prostate cancer tumor marker (Lloyd et al. 2008). 
AMACR is an accessory enzyme in the α-oxidation path-
way for phytanic acid and required for the conversion of 
2R-methylacyl-CoA into 2S-methylacyl-CoA (Wanders and 
Waterham 2006). 2S-Pristanoyl-CoA is further degraded 
via the peroxisomal β-oxidation pathway for 2-methyl 
branched-chain fatty acids. Subsequent studies have revealed 
that expression of other enzymes involved in the peroxi-
somal branched-chain fatty acid degradation pathway (e.g. 
ACOX3, D-PBE, and the 3-ketoacyl-CoA thiolase ACAA1) 
is increased in prostate tumors (Zha et al. 2005; Valença 
et al. 2015). Moreover, the monocarboxylate transporter 2 
(MCT2) (Fig. 1) was recently shown to reallocate in per-
oxisomal membranes of malignant prostate cancer cells 
(Valença et al. 2015). Monocarboxylate transporters could 
be responsible for the shuttling of lactate–pyruvate to re-
oxidize NADH to regenerate  NAD+ as a cofactor for peroxi-
somal β-oxidation (McClelland et al. 2003). These findings 
might point to a specific elevation of peroxisomal branched-
chain fatty acid metabolism in prostate tumors. Interestingly, 
elevated AMACR expression was also reported from colon, 
gastric, breast, renal and hepatocellular carcinoma (Jiang 
et al. 2003; Witkiewicz et al. 2005; Chen et al. 2005; Went 
et al. 2006; Jindal et al. 2016) suggesting that peroxisomal 
branched-chain metabolism might be associated with a 
broader variety of tumors. In this regard, it is tempting to 
speculate why the degradation of branched-chain fatty acids 
might be elevated in prostate and other tumors. One possi-
bility is a correlation between elevated serum phytanic acid 
levels, which could lead to the induction of AMACR, and 
the occurrence of prostate cancer, which has been reported 
(Xu et al. 2005) but is currently under debate (Kataria et al. 
2015). Moreover, a reduction in AMACR expression by 
RNAi has been reported to reduce the growth rates of the 
prostate cancer cell line LAPC-4 (Zha et al. 2003). Human 
AMACR deficiency is represented by variable phenotypes 
including childhood cholestasis, late-onset peripheral neu-
ropathy, pigmentary retinopathy or seizures but is not associ-
ated with increased tumor development (Ferdinandusse et al. 
2000). These findings suggest that metabolites downstream 
of AMACR might be the active compounds triggering can-
cer development, e.g. by activating receptors of relevant 
signalling pathways such as PPARs or RXRs. On the other 
hand, more general alterations in lipid metabolism have been 
proposed to interfere with the tumor development (Wu et al. 
2014). To substantiate the latter, data on the levels of further 
enzymes and lipid metabolites associated with peroxisomal, 
mitochondrial and ER metabolism would be required to 
increase our insights into the pathology of prostate cancer. 
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In addition to the enzymes of the peroxisomal branched-
chain fatty metabolism, the peroxisomal membrane protein 
PMP24/PXMP4 has been associated with the develop-
ment of prostate cancer. In contrast to the former, however, 
PMP24 has been reported to be silenced by methylation of a 
single intronic CpG during the transition of the prostate can-
cer cell line LNCaP from androgen dependence to androgen 
independence (Wu and Ho 2004; Zhang et al. 2010). PMP24 
is a member of the TIM17 family of membrane proteins 
(Fig. 1) but its function is currently unknown. Nevertheless, 
the findings indicate that peroxisomes might be involved at 
different stages during the transition of healthy prostate tis-
sue into malignant cancer cells.
Peroxisomes in glioblastomas have been investigated with 
respect to tumor grade progression (Benedetti et al. 2010). 
In correlation with the progressing tumor grade an increas-
ing staining for peroxisomes was observed using immuno-
cytochemistry. These findings were validated by detection 
of the proteins Pex14, PMP70, ACOX1, and 3-ketothiolase 
using immunoblotting, which indicate peroxisome prolif-
eration leading to increased organelle numbers. In parallel, 
the tumors showed multiple lipid droplets and an elevated 
expression of PPARα. In a follow-up study, the authors 
investigated the influence of hypoxic conditions on per-
oxisomes in primary cultures of Glioblastoma multiforme 
(GBM) tumors (Laurenti et al. 2011). According to PMP70 
immunofluorescence staining, an increase in peroxisomes 
and lipid droplets was reported. In parallel, an induction of 
the hypoxia-inducible factor Hif1α and PPARα was observed 
in response to hypoxia. The authors concluded that Hif1α 
activation under the hypoxic conditions in a tumor might 
induce PPARα expression, which subsequently triggers per-
oxisome proliferation. Nevertheless, it remains to be clarified 
why PPARα-induction, which generally induces catabolic 
lipid metabolism, correlates with the increased abundance of 
lipid droplets in the GBM cells. After observing an increase 
in HMG-CoA reductase as well as cholesterol and triglyc-
eride levels in the cultures, the authors hypothesized that 
peroxisomal β-oxidation under hypoxic conditions might be 
used to produce acetyl-CoA as a substrate for de novo lipid 
synthesis. Another recently identified peroxisomal protein, 
HSDL2 (hydroxysteroid dehydrogenase-like 2) also appears 
to be up-regulated in glioblastomas (Ruokun et al. 2016) and 
ovarian cancer (Sun et al. 2018). Knockdown of HSDL2 
resulted in decreased growth rates in glioblastoma cell lines, 
and inhibited cell proliferation, colony formation, motility, 
and tumorigenesis in ovarian cancer cells underlining an 
important role for peroxisomes in these tumor types. At the 
current stage, further data are required to decipher if peroxi-
somes play a role in the metabolic transformation of glial 
cells into malignant glioblastoma.
Peroxisomes are dynamic organelles which are able 
to adapt their number and enzyme content to the specific 
requirements of their cellular environment (Schrader et al. 
2015). Therefore, it has to be considered that drugs applied 
in therapeutic cancer intervention might remodel peroxi-
somes thereby influencing tumor physiology. Dahabieh 
and colleagues investigated the reaction of peroxisomes to 
Vorinostat, a HDAC inhibitor used for lymphoma treatment, 
which promotes ROS-mediated apoptosis to evaluate their 
potential role in resistance to tumor intervention (Dahabieh 
et al. 2017). The study revealed that peroxisomes in cul-
tured lymphoma cells were indeed up-regulated in response 
to Vorinostat administration. Consequently, knockdown of 
Pex3 or more specifically catalase significantly increased 
ROS-mediated apoptosis in the lymphoma cells in response 
to Vorinostat treatment. Thus, peroxisomes, which are ROS-
degrading organelles, have to be considered to play a role 
in resistance to therapeutic tumor intervention when drugs 
inducing ROS-mediated apoptosis are applied.
Wu and coworkers observed an increased expression 
of the peroxisomal Lon protease LonP2 in cervical can-
cer tissue (Wu et al. 2018). Functionally, LonP2 fulfils 
the function of a combined chaperone/protease, refolding 
or degrading compromised peroxisomal proteins (Barto-
szewska et al. 2012). A down-regulation of LonP2 in the 
tumor cell lines HeLa and SiHA reduced oxidative stress 
and inhibited cervical cancer cell proliferation and migration 
(Wu et al. 2018). As the study, however, lacks any further 
analysis on the peroxisomal status in the cervical cancer 
cells or LonP2 depleted cell lines, it is currently impossible 
to mechanistically explain how the changes in LonP2 expres-
sion might modify peroxisome physiology with respect to 
cancerogenesis.
Most of the studies described above focus on the meta-
bolic role of peroxisomes in tumor development. Interest-
ingly, a recent publication might add an unexpected function 
of peroxisomes in the control of correct cell division (Asare 
et al. 2017). The study reveals that correct peroxisome posi-
tioning during mitosis is required for the correct asymmetric 
cell division in skin epithelial cells. RNAi-mediated knock-
down of Pex11β and Pex14 resulted in mitotic delay in the 
targeted cells and led to an imbalance in growth and differ-
entiation into basal and supra-basal skin cells accompanied 
by a reduction in terminal differentiation markers in the tis-
sue. Remarkably, the mitotic dysregulation was not associ-
ated with a disruption in peroxisomal metabolic functions 
but was found to be caused by a mislocalization of peroxi-
somes during spindle formation. Under normal conditions, 
peroxisomes are positioned at the spindle poles whereas a 
deviating localization resulted in uncontrolled spindle rota-
tions and triggered an arrest at a mitotic check point for 
organelle segregation (Asare et al. 2017). Summarizing 
their results the authors concluded that proper peroxisome 
inheritance has a role in controlling the balance between cell 
growth and differentiation. Perturbations in this system lead 
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to the generation of basal daughter cells with differentiation 
markers but still proliferating features typically associated 
with cancer (Asare et al. 2017).
In summary, our current view on the role of peroxisomes 
in cancer cells remains fragmentary and while earlier pub-
lications mainly reported a decrease in peroxisome activity 
in many tumors, more recent studies also suggest that spe-
cific peroxisome functions are required for efficient tumor 
growth. These cursorily contradictory findings might result 
from the vast heterogeneity of tumors analysed. Moreover, a 
single tumor itself does not represent a single cell type, fur-
ther complicating the interpretation of results. To substanti-
ate our current understanding on the status of peroxisomes 
in tumors, extensive comparative studies would be required 
to associate potential peroxisome dysfunction with tumor 
type and grade as well as the metabolic status of the tissue.
Concluding remarks
During the last 6 years, following the publication of our 
second ‘‘mystery’’ review (Islinger et al. 2012a, b), the view 
on peroxisome biology has further widened, adding new 
important discoveries in the areas of peroxisome function, 
biogenesis, formation, division and motility, and unveiled 
new proteins and machineries at the peroxisomal membrane 
and further insights into peroxisome–organelle interaction 
and cooperation. With regard to protein import, new perox-
ins and alternative import pathways have been identified and 
progress has been made in the understanding of the export 
and recycling of the ubiquitinated import receptors Pex5 and 
Pex7 via the Pex1/Pex6 complex. Concerning the process 
of peroxisome formation, several unexpected observations 
in different model organisms have given new mechanistic 
twists such as indirect targeting of PMPs, ER- and mitochon-
dria-driven pre-peroxisomal vesicle formation and de novo 
formation of peroxisomes. This resulted in a more complex 
model of peroxisome formation, and a challenge in the field 
is to build an overall understanding of the general process 
(reviewed in Costello and Schrader 2018). The discovery 
of new peroxisome–organelle contact sites and molecules 
involved in tethering has broadened our thinking on peroxi-
some cooperation and crosstalk with other compartments, 
in particular, with respect to associated diseases, where the 
role and importance of contact sites are only now starting to 
be revealed. It will be a challenge for the future to develop 
techniques to identify the proteins that mediate contacts and 
metabolic channelling, especially those transferring lipids 
from the ER to peroxisomes for membrane expansion and 
division. The field of membrane contacts and organelle 
cooperation is just in its infancy, and new contact sites, com-
ponents, functions, and regulators await discovery. It is also 
now evident that peroxisomes are key metabolic organelles 
with protective functions and a wider significance in human 
health with potential impact on a large number of globally 
important human diseases such as neurodegenerative dis-
orders, obesity, cancer, and diabetes (Elsner et al. 2011; 
Zhou et al. 2018). Further systematic studies are required 
to validate if peroxisome alterations/dysfunctions primarily 
contribute to the disease aetiology or if these are secondary 
changes reflecting a general decline in cellular fitness with 
disease progression. In addition, the functional correlation 
between disease pathogenesis and alterations in peroxisome 
physiology has to be deciphered. Other rapidly developing 
research areas include the role of peroxisomes in cellular 
redox balance and redox signalling (Fransen and Lismont 
2018) and in antiviral signalling and defence (Wong et al. 
2018). Peroxisomes are still among the more mysterious 
subcellular compartments in eukaryotic cells, but there is 
no doubt that they are “on the rise” and poised to reveal 
more surprises in the near future.
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